COMPOUNDS TO PROVIDE A LONG-LASTING FLORAL AND FRUITY SCENT.
Patent Information
- Application Number
- MX2022002595
- Authority / Receiving Office
- MX · MX
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-12-19
- Filing Date
- 2022-03-02
- Publication Date
- 2026-05-19
- Estimated Expiration
- 2040-12-17
AI Technical Summary
Existing perfumes and fragrances have limited longevity due to high volatility, causing floral and fruity notes to evaporate quickly, failing to provide a long-lasting odor experience.
Development of non-volatile compounds of formula (I) that react with ambient conditions to form odor-emitting substances, such as alpha-damascone and beta-damascone, which are stable in perfume compositions and release a fresh green, floral, and fruity odor over extended periods.
The compounds of formula (I) effectively provide a long-lasting floral and fruity odor by forming odor-emitting substances upon exposure to environmental factors, enhancing perfume duration and intensity.
Abstract
Description
COMPOUNDS TO PROVIDE A LONG-LASTING FLORAL AND FRUITY SCENT Field of Invention The present invention relates to the field of perfumery. The present invention relates to the compounds of formula (I) capable of imparting a long-lasting or substantial odor, in particular a fresh green, floral, and / or fruity scent, to the environment. Furthermore, the present invention relates to a method for imparting a long-lasting odor, in particular a fresh green, floral, and / or fruity scent, to surfaces, such as hard surfaces, fabrics, skin, or hair. Additionally, the present invention relates to the use of the compounds in perfumery, as well as to perfume compositions or perfumed articles comprising the compounds of the invention. Background of the Invention Consumers often correlate the effectiveness of scented products with the duration or substantivity of the fragrance's perception. Perfumes are composed of multiple different volatile compounds, which are applied to a surface from which they evaporate, allowing them to be smelled. Perfume is applied to surfaces, such as hard surfaces, fabrics, skin, or hair, through a perfume composition or a consumer product. CRCznn / zznz / E / YiAi Ref. 331878 perfumed, such as, for example, fine fragrances or various washing and cleaning agents. Due to the high volatility of the fragrances that make up perfumes, the scent emitted by the perfumed surface can only be perceived for a limited time. In particular, the so-called top notes of a perfume evaporate quite quickly. These are the most volatile compounds in the composition and represent the freshness of a perfume. Top notes typically include, among others, citrus, floral, green, and fruity notes, with floral and fruity notes being especially appreciated by consumers. Various types of floral and fruity notes are used in perfumes. Typical examples of fruity notes are those resembling blackcurrant, cassis, and exotic fruits, as well as red fruits such as raspberries or strawberries. Consumers seek fragrances that are stable on the intended application and, at the same time, long-lasting or substantial enough to be smelled for several hours or even days after application. In particular, long-lasting floral and fruity notes are desirable. Therefore, the objective of the present invention is to provide a system capable of supplying a long-lasting or substantial odor, in particular a floral and / or fruity odor, but also other odors, such as tones CRCznn / zznz / E / YiAi fresh green and minty scents to the environment. Furthermore, another objective of the present invention is to find a method for imparting a long-lasting scent, in particular a fresh green, floral and / or fruity scent, to surfaces, such as hard surfaces, fabrics, skin or hair, through the application of the perfume compositions or perfumed articles. Detailed Description of the Invention It has now been discovered that some specific compounds can be advantageously employed to produce a long-lasting or substantive perfume effect, in particular a fresh green, floral and / or fruity scent note, from a given surface into the environment, and are therefore going to be useful as ingredients for perfume compositions or perfumed articles. Therefore, a first aspect of the present invention relates to a compound of the formula R1R1' CRCznn / zznz / E / YiAi where R1 and R1' independently represent either a hydrogen atom or a methyl group; or, both R1 and / or both R1', when taken together, represent a group of C3 to Cs bivalent hydrocarbons, R2 and R2' independently represent either a hydrogen atom or a hydrocarbon group from C1 to C12, R3 and R3' independently represent one another hydrogen atom or hydrocarbon group from Ci to Cie; R1 and R3 and / or R1' and R3' taken together may be connected with a C2 to C12 divalent hydrocarbon group, Q represents a C2 to C22 divalent hydrocarbon group, optionally comprising one to eight ether groups and / or one or two functional groups selected from the group consisting of alcohol, ketone, aldehyde, ester, thioether, carboxylic acid, alkali carboxylate, amine, amide, carbamate, nitrile, or thiol; and each X independently represents any one of the groups in formulas (i) to (iii) CRCznn / zznz / E / viAi where the wavy line indicates the location of the bond between carbons 2 and 2' and X and the dashed line indicates the location of the bond between X and Q, provided that the dashed line is not directly attached to a heteroatom or a carbonyl functional group of Q. It is understood that by ... hydrocarbon group... It is proposed that the group consists of hydrogen and carbon atoms and that it may be in the form of an aliphatic hydrocarbon, i.e., a linear or branched saturated hydrocarbon (e.g., an alkyl group), or a linear or branched unsaturated hydrocarbon (e.g., an alkenyl or alkynyl group), a saturated cyclic hydrocarbon (e.g., a cycloalkyl) or an unsaturated cyclic hydrocarbon (e.g., a cycloalkenyl or cycloalkynyl), or it may be in the form of an aromatic hydrocarbon, i.e., an aryl group, or it may also be in the form of a mixture of the types of groups, e.g., a specific group may comprise a linear alkyl, a branched alkenyl (e.g., having one or more carbon-carbon double bonds), a (poly)cycloalkyl and an aryl portion, unless a specific limitation to a single type is mentioned.Similarly, in all embodiments of the invention, when it is stated that a group is in the form of more than one type of topology (e.g., linear, cyclic, or branched) and / or that it is saturated or unsaturated (e.g., alkyl, aromatic, or alkenyl), it is also understood that a group may comprise portions having any of the topologies or being saturated or unsaturated, as explained above. Likewise, in all embodiments of the invention, when it is stated that a group is in the form of a type of saturation or unsaturation (e.g., alkyl), it is understood. CRCznn / zznz / E / YiAi that the group can be in any type of topology (e.g., linear, cyclic, or branched) or that they have several portions with various topologies. It is understood that the terms "...a hydrocarbon group, optionally comprising..." and "...a hydrocarbon group, optionally substituted with..." are intended to mean that the hydrocarbon group optionally comprises alcohol, benzoin, aldehyde, ether, thioether, ester, carboxylic acid, alkali carboxylate, amine, amide, carbamate, nitrile, or thiol groups. These groups may either substitute a hydrogen atom of the hydrocarbon group and thus be laterally bonded to the hydrocarbon, or substitute a carbon atom (if chemically possible) of the hydrocarbon group and thus be inserted into the hydrocarbon chain.For example, a -CH2-CH2-CHOH-CH2- group represents a C4 hydrocarbon group comprising an alcohol group (substitution of one hydrogen atom), a -CH2-CH2-COO-CH2-CH2-OCO-CH2-CH2- group represents a Ce hydrocarbon group comprising two ester groups (substitution of carbon atoms / insertion into the hydrocarbon chain), and similarly, a -CH2-CH2-O-CH2-CH2-O-CH2-CH2- group represents a Ce hydrocarbon group comprising two ether groups. In one embodiment of the invention, the two X groups attached to Q are separated from each other by at least four atoms. CRCznn / zznz / E / YiAi of carbon. The term "the two X groups attached to Q are separated from each other by at least four carbon atoms" means that there are at least four carbon atoms other than Q between one X group and the second X group. These four carbon atoms can be part of any substituted or unsubstituted hydrocarbon group, provided that the shortest possible path from one X group to the other X group passes through at least four carbon atoms other than Q. In a preferred embodiment, the two X groups attached to Q are separated from each other by at least five, preferably six, carbon atoms. According to any embodiment of the invention, all R1 and R1', R2 and R2', and R3 and R3' in formula (I) may be different, preferably R1 and R1', R2 and R2', and R3 and R3' in formula (I) are equal in pairs. In this document, the expression R1 and R1' are understood to independently represent either the indicated substituent, i.e., a hydrogen atom or a methyl group; or, both R1 and / or both R1', when taken together, represent a C3 to C5 divalent hydrocarbon group. In other words, R1α with respect to the carbonyl group can be a hydrogen atom or a methyl group, while R1α relative to R2 can be independently represented by either substituent. CRCznn / zznz / E / YiAi of the same a hydrogen or a methyl group and the alpha R1' with respect to the carbonyl group can be a hydrogen atom or a methyl group, while the geminal R1' to R2' can independently be a hydrogen atom or a methyl group; or, both R1 and / or both R1', when taken together, represent a divalent hydrocarbon group from C3 to Cs. In a particular embodiment, both R1 represent a hydrogen atom or a methyl group and independently of the same both R1' represent a hydrogen atom or a methyl group; or both R1 and / or both R1', when taken together, represent a divalent hydrocarbon group from C3 to Cs. According to any embodiment of the invention, each of R1 and R1' independently may preferably represent a hydrogen atom or a methyl group, preferably each of R1 and R1' independently may be a hydrogen atom. According to any embodiment of the invention, each of R2 and R2' independently may preferably represent a hydrocarbon group from C1 to C12, more preferably a hydrocarbon group from C1 to C10, preferably each of R2 and R2' independently may be a methyl group, an ethyl group, an alkyl or alkenyl group from C1 to C10 or a cycloalkyl or cycloalkenyl group from C5 to C10 optionally substituted with one to three alkyls from C1 to C3 or alkenyls from C2 to C3, preferably each of CRCznn / zznz / E / viAi R2 and R2' can independently be a methyl group, an ethyl group, or an alkyl or alkenyl group from Ce to Cío; even more preferably, each of R2 and R2' can independently be a methyl group. According to a particular modality, each of R2 and / or R2' independently may preferably represent a hydrogen atom when both R1 and / or both R1', when taken together, represent a divalent hydrocarbon group from C3 to Cs or when R1, geminal to R2, and R3 and / or R1', geminal to R2, and R3' taken together can be connected to a divalent hydrocarbon group from C2 to C12. In other words, each of R2 and / or R2' independently may not represent a hydrogen atom when at least one molecule to be released does not comprise a ring; that is, both R1 and / or both R1' taken together or R1, geminal to R2, and R3 and / or R1', geminal to R2, and R3' taken together form a ring. According to any embodiment of the invention, each of R3 and R3' can preferably represent a hydrogen atom or a hydrocarbon group from Ci to C10, each of R3 and R3' can independently represent a hydrocarbon group from Ci to Cg, more preferably each of R3 and R3' can independently represent a C4 hydrocarbon group, and even more preferably each of R3 and R3' can independently represent an n-butyl group. CACznn / zznz / E / YiAi According to any embodiment of the invention, R1 and R3 and / or R1' and R3', when taken together, may preferably represent a group of C2 to Ce bivalent hydrocarbons. According to any embodiment of the invention, both R1 and both R1', when taken together, can form a C5-8 cycloalkyl group or a C5-8 cycloalkenyl group, each optionally substituted with one to three C1-8 alkyl groups or C5-8 alkenyl groups. The terms alkyl and alkenyl are understood to include branched and linear alkyl and alkenyl groups. The terms alkenyl and cycloalkenyl are understood to include 1, 2, or 3 olefinic double bonds, preferably 1 or 2 olefinic double bonds. The terms cycloalkyl and cycloalkenyl are understood to include fused, spiro, and / or bridged monocyclic, bicyclic, or tricyclic cycloalkyl and cycloalkenyl groups, preferably monocyclic cycloalkyl and cycloalkenyl groups. According to any embodiment of the invention, Q may preferably represent a divalent hydrocarbon group from C4 to C22, preferably from C4 to C5, more preferably from C5 to C1a, optionally comprising one to eight ether groups and / or with one or two functional groups selected from the group consisting of alcohol, ketone, aldehyde, ester, carboxylic acid, amine, amide or carbamate. CRCznn / zznz / E / YiAi Preferably, Q may represent a divalent alkyl or alkenyl group from C2 to C12, preferably from C4 to C12, more preferably from C5 to C12, optionally comprising one to six ether groups and / or with one or two functional groups selected from the group consisting of alcohol, ester, carboxylic acid, amine, or carbamate. Preferably, Q may represent a divalent alkyl or alkenyl group from C3 to C12, preferably from C4 to C12, more preferably from C5 to C12, optionally comprising one to four ether groups, or a divalent alkyl group from C4 to C12, optionally comprising one to four ether groups. More preferably, Q can represent a divalent alkyl from C2 to Gis, preferably from C4 to Gis, more preferably from C5 to Cie, an alkenyl from C2 to Cie, preferably from C4 to Cie, more preferably from C5 to Cie or a mono, di, tri or tetraoxoalkyl group from C4 to Cie. According to a particular embodiment, Q may represent a butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, 3-oxapentyl, 3,6-dioxaoctyl, 3,6,9-trioxaundecyl, or divalent 3,6,9,12-tetraoxatetradecyl group, more preferably Q may represent a hexyl, octyl, decyl, dodecyl, 3-oxapentyl, 3,6-dioxaoctyl, 3,6,9-trioxaundecyl, or divalent 3,6,9,12-tetraoxatetradecyl group, even more preferably Q may represent a divalent 3,6-dioxaoctyl group. According to any embodiment of the invention, CRCznn / zznz / E / viAi each X can preferably represent the same group selected from formulas (i) to (iii) . According to any embodiment of the invention, preferably each X can independently represent a group of formula (i) or (ii), more preferably a group of formula (i). According to a particular embodiment, R1 and R1' may represent a hydrogen atom or a methyl group, R2 and R2' may represent a methyl or ethyl group, and R3 and R3' may represent a hydrogen atom or a hydrocarbon group from C1 to C10. R1 and R3 and / or R1' and R3', when taken together, may represent a divalent hydrocarbon group from C2 to C6. X may represent the groups of formulas (i) and / or (ii), and Q may represent a divalent alkyl or alkenyl group from C2 to C10, preferably from C4 to C10, optionally comprising one to four ether groups and / or with one or two functional groups selected from the group consisting of ester, alcohol, amine, or carbamate. In a particular embodiment of the invention, the following compounds are excluded from the compound of formula (I): 3,3'-(ethane-1,2-diylbis(sulfanediyl))dipropanal, 3,3'-(propane-1,3-diylbis(sulfanediyl))dipropanal, 3,3'-(butane-1,4-diylbis(sulfanediyl))dipropanal, 3,3'-((oxybis(ethane-2,1-diyl))bis(sulfanediyl))dipropanal, ethane-1,2-diyl bis(2-((3-oxopropyl)thio)acetate), 3,3'-(butane-1,4-diyldisulfonyl)dipropanal, 4,4-(ethane-1,2-diylbis(sulfanediyl))bis(butan-2-one), 4,4'-(propane-1,3diylbis(sulfanediyl))bis(butan-2-one), 4,4'- (butane-1,4diyldisulfonyl)bis(butan-2-one), 4,4'-(propane-2,2diylbis(sulfanediyl))bis(butan-2-one), 4,4'- (propane-2,2diylbis(sulfanediyl))bis(4-methylpentan-2-one) 4,4'-(pentane-3,3-diylbis(sulfanediyl))bis(4-methylpentan-2one), 4,4'-(pentane-2,2-diiibis(sulfanediyl))bis(4methylpentan-2-one), 4,4'-(heptano-3,3diylbis(sulfanodiyl))bis(4-methylpentane-2-one) , 1,1'-(propano2,2-diiIbis(sulfanodiyl) )bis(hex-5-en-3-one) , 1,1'-(heptano3,3-diylbis(sulfanodiyl)-5-hex-one),( 1,1'- (propano2,2-diylbis(sulfanodiyl) )bis (hept-5-en-3-one), 3,3'-(propano2,2-diiIbis(sulfanodiyl) )bis (1-cyclohexylpropan-l-one), 3,3'(hexano-2,2-diylbis(sulfanodiyl))bis(1-cyclohexylpropan-lona) , 5,5'- (propano-2,2-diylbis(sulfanodiyl) )bis(1cyclohexylpentane-3-one), 3,3'- (propano-2,2diylbis (sulfanodyl))bis(1-phenylpropan-1-one) , 3,3'- (propano2,2-diylbis(sulfanodiyl) )bis(1- (naphthalene-2-yl)propan-1-one), 3,3'-(propano-2,2-diylbis(sulfanodyl))bis(1,3-diphenyl-propane), 4,4'-(methylenebis(sulphanodiyl) )bis(4-phenylbutan-2ona) , 3,3'-(propano-2,2-diylbis(sulfanodiyl) )bis (1,3diphenylbutan-l-ona) , 3,3'-(propano-2,2CRCznn / zznz / E / YiAi diiIbis(sulfanodiyl))bis(1-(p-tolyl)propan-1-one), 3,3'(propano-2,2-diiIbis(sulfanodiyl))bis(1-(3,5dimethylphenyl)propane-1-one), 3,3'-(propano-2,2diylbis(sulfanodyl))dipropanal, 3,3'-(propano-2,2diylbis(sulfanodyl))dibutanal, 3,3'-(propano-2,2diylbis(sulfanodyl))bis(3-phenyIpropanal) ,4,4'((phenylmethylene)bis(sulfanodiyl))bis(butane-2-one),4,4'((phenylmephylene)bis(sulfanodiyl))bis(4-methylpentane-2-one), 3,3'- (butano-1,1-diylbis(sulfanodiyl) )dipropanal,3,3(bisphenyl bis(sulfanodiyl))() (3-phenyIpropanal),4,4'(butano-1,1-diylbis(sulfanodiyl))bis(4-methylpentane-2-one), 3,3'-(ethano-1,2-diiIbis(sulfanodiyl))bis(cyclopentane-1-one), 3,3'-(propano-1,3-diylbis(sulfanodiyl))bis(cyclopentane-1ona) , 3,3'-(ethano-1,2-diiIbis(sulfanodiyl))bis(cyclohexane-1ona), 3,3'-( (propano-1,3diylbis(sulfanodiyl))bis(methylene))bis(cyclohexan-1-one), 4,4'-(naphthalene-1,5-diibis(sulfanodiyl))bis(butan-2-one), 3,3'-(propano-2,2-diylbis(sulfanodiyl))bis(sulfanodiyl) clohexylpropan-1-one),4,4'-(1,3phenylenebis(sulfanediyl))bis(4-phenylbutan-2-one), 3,3'-(ethane1,2-diiIbis(sulfanediyl))bis(1,3-diphenylpropan-1-one), 2,3bis((2-(4-methyl-2-oxocyclohexyl)propan-2-yl)thio)naphthalen-1,4dione, 4,4'-(methylenebis(4,1-phenylenesulfonyl))bis(4methylpentan-2-one) and 4,4'-([1,1'-biphenyl]-4,4' disulfonyl)bis(4-methylpentan-2-one). In particular, the The following compounds are excluded from the compound of formula (I): 4,4'-(methylenebis(4,1-phenylenesulfonyl) )bis(4-methylpentan2-one) and 4,4'-( [1,1'-biphenyl]-4,4'-disulfonyl)bis(4-methylpentan-2-one). In a particular embodiment of the invention, the following compounds are excluded from formula (I): bis(2((4-oxooctan-2-yl)thio)acetate) of ethane-1,2-diyl. In a particular embodiment of the invention, the following compounds are excluded from formula (I): 1,2-diyl C2-2o-bis(2-((4-oxooctan-2-yl)thio)acetate) alkyl, 1,2-diyl C2-2o-bis(2-((4-oxooctan-2-yl)sulfinyl)acetate) alkyl and / or 1,2-diyl C2-2o-bis(2-((4-oxooctan-2-yl)sulfonyl)acetate) alkyl. According to one embodiment, the compound of formula (I) can be either a homodimer or a heterodimer. For the purposes of this document, a homodimer is understood to mean that the two substituents attached to X (and not comprising Q) have the same chemical structure. For the purposes of this document, a heterodimer is understood to mean that the two substituents attached to X (and not comprising Q) have different chemical structures. In other words, the group R3C(=O)CHR1CR2R1 and the group R3'C(=O)CHR1'CR2'R1' can be identical or different; they are, respectively, a homodimer or a heterodimer. According to any embodiment of the invention, the compound of formula (I) is preferably a compound CRCznn / zznz / E / YiAi of the formula R1 CRCznn / zznz / E / YiAi where R1, R2, R3, X and Q have the same meaning as indicated in formula (I), even more preferably, the compound of formula (I) is a compound of the formula OO where X and Q have the same meaning as indicated for the compound of formula (I). According to any of the above embodiments, the compound of formula (I) is a 2,2'-(alkanoa,ω-diylbis(sulfanediyl))bis(octan-4-one) with the size of the alkyl group varying between C4 and C22, preferably between C4 and cis, even more preferably between C5 and cis, such as the 2,2'-(hexano-1,6-diylbis(sulfanodiyl) )bis(octane-4-one), 2,2' (heptano-1,7-diibis(sulfanodiyl))bis(octane-4-one), 2,2'(octano-1,8-diibis(sulfanodiyl))bis(octane-4-one), 2,2'(nonano-1,9-diibis(sulfanodiyl))bis(octane-4-one), 2,2'(decano-1,10-diibis(sulfanodiyl))bis(octane-4-one), 2,2' (undecano-1,11-diiibis(sulfanodiyl))bis(octane-4-one) 2,2'(dodecano-1,12-diylbis(sulfanodiyl))bis(octane-4-one), a 2,2'-(oxaalkane-α,ω-diylbis(sulfanediyl))bis(octan-4-one) with the size of the alkyl group varying between C4 and C22, preferably between C4 and C5, even more preferably between C4 and C12 and with the alkyl group comprising one to four ether groups, such as 2,2'-(3-oxapentane-α,5-diylbis(sulfanediyl))bis(octan-4-one), 2,2'-(3,6-dioxaoctane-α,8-diylbis(sulfanediyl))bis(octan-4-one), 2,2'-(3,6,9-trioxaundecane-α,11-diylbis(sulfanediyl))bis(octan-4-one) or 2,2'-(3,6,9,12-tetraoxatetradecane-l,14diylbis(sulfanediyl))bis(octan-4-one), a 2,2'-(alkane-a,Gdiyldisulfonyl)bis(octan-4-one), with the size of the alkyl group varying between C4 and C22, preferably between C4 and Gis, further preferably between C5 and Cie, such as 2,2'(hexane-1,6-diyldisulfonyl)bis(octan-4-one), 2,2'-(heptane1,7-diyldisulfonyl)bis(octan-4-one), 2,2'-(octane-1,8diyldisulfonyl)bis(octan-4-one), 2,2'-(nonane-1,9diyldisulfonyl)bis(octan-4-one), 2,2'-(decane-1, 10diyldisulfonyl)bis(octan-4-one), 2,2'-(undecan-1,11diyldisulfonyl)bis(octan-4-one) or 2,2'-(dodecan-1,12diyldisulfonyl)bis(octan-4-one) or a 2,2'-(oxaalkane-α,ωdiyldisulfonyl)bis(octan-4-one) with the size of the algyl group varying between C4 and C22,1. preferably between C4 and Cíe, even more preferably between C4 and C12 and with the algyl group comprising from one to four ether qroupes, such as 2,2'-(3-oxapentano-l,5-diyldisulfonyl)bis (octan-4-one), 2,2'-(3,2). 6-dioxaoctan-l,8-diyldisulfonyl)bis(octan-4-one), CACznn / zznz / E / YiAi 2,2'-(3,6,9-trioxaundecano-l,ll-diyldisulfonyl)bis(octan-4one) or 2,2'-(3,6,9,12-tetraoxatetradecano-1,14 diyldisulfonyl)bis(octan-4-one). According to any embodiment of the invention, the compound of formula (I) of formula is preferably a compound R1 TA i <IC) o ' ^R1en donde R1, R2, R3, X y Q tienen el mismo significado que se indica en la fórmula (I), y en donde las líneas punteadas representan la ubicación de un enlace sencillo o doble, aún más preferentemente, el compuesto de la fórmula (I) es un compuesto de la formula where R1, X and Q have the same meaning as indicated for the compound of formula (I), and where the dotted lines represent the location of a single or double bond. According to any of the above modalities, the compound of formula (I) is 3,3'-(alkane α,ω-diylbis(sulfanediyl))bis(1-(2,6,6-trimethylcyclohex-l-, 219 o 3-en-l-yl)butan-l-ona), 3,3'-(alcano-α,ωdiilbis(sulfanodiil))bis(1-(6-ethyl-2,6-dimetiIciclohex-3-enl-yl )butan-l-ona), 3,3'- (alcano-α,ωdiilbis(sulfanodiil))bis(2-meti1-1-(2,6,6-trimetilciclohex-l, 2- o 3-en-l-yl)butan-l-ona) o 3,3'-(alcano-α,ωdiilbis(sulfanodiil))bis(1-(2,6,6-trimetilciclohex-l,3-dien1-yl)butan-l-ona) con el tamaño del grupo alquilo varía entre C4y C22, preferentemente entre C4y Gis, even more preferably between C5 and Cíe, such as 3,3'-(hexano-1,6diylbis(sulfanodiyl))bis(1-(2,6,6-trimethylcyclohex-l-, 2- or 3en-l-yl)butan-l-ona), 3,3'- (hexano-1,6diylbis(sulfanodiyl))bis(1-(6-ethyl-2,6-dimethylcyclohex-3-en1-yl)butan-l-ona), 3,3'- (hexano-1,6diylbis(sulfanodiyl))bis(2-methyl-l-(2,6,6-trimethylcyclohex-l-, 2- o 3-en-l-yl)butan-l-ona), 3,3'-(hexane-1,6diylbis(sulfanodiyl))bis(1-(2,6,6-trimethylcyclohex-l,3-dien1-yl)butan-l-one), 3,3'-(heptane-1,7diylbis(sulfanodiyl))bis(1-(2,6,6-trimethylcyclohex-l-, 2- or 3en-l-yl)butan-l-one), 3,3'-(octane-1,8diylbis(sulfanodiyl))bis(1-(2,6,6-trimethylcyclohex-1-, 2- or 3en-l-yl)butan-l-one), 3,3'-(nonane-1,9diylbis(sulfanodiyl))bis(1-(2,6,6-trimethylcyclohex-1-, 2- or Βοή- 1 -i 1) butan-l-one), 3,3'-(decane-1,10diylbis(sulfanodiyl))bis(1-(2,6,6-trimethylcyclohex-1-, 2- or 3en-1-yl)butan-l-one), 3,3'-(undecane-1,11, CRCznn / zznz / E / viAi diylbis(sulfanodiyl))bis (1-(2,6,6-trimethylcyclohex-l-, 2- or 3en-l-yl)butan-l-ona) or 3,3'-(dodecane-l,12diylbis(sulfanodiyl))bis(1-(2,6,6-trimethylcyclohex-l-, 2- or 3en-l-yl)butan-l-ona), 3,3'- (oxaalkane-α,ωdiylbis(sulfanodiyl))bis(1-(2,6,6-trimethylcyclohex-l-, 2- or 3en-l-yl)butan-l-ona), 3,3'- (oxaalcano-α,ωdiilbis(sulfanodiil))bis(1-(6-ethyl-2,6-dimethylcyclohex-3-en1-yl)butan-l-ona), 3,3'- (oxaalcano-α, ωdiilbis(sulfanodiil))bis(2-metí1-1-(2,6,6-trimethylcyclohex-l-, 2- o 3-en-l-yl)butan-l-ona) o 3,3'-(oxaalcano-α,ωdiilbis(sulfanodiil))bis(1-(2,6,6-trimethylcyclohex-l,3-dien1-yl)butan-l-ona) con el tamaño del grupo alquilo que varía entre C4 y C22, preferentemente entre C4 y Cis, aún más preferentemente entre C4 y C12 and with the alkyl group that includes one to four ether groups, such as 3,3'-(3oxapentane-1,5-diibis(sulfanodiyl))bis(1-(2,6,6trimethylcyclohex-1-, 2- or 3-en-l-yl)butan-l-ona), 3,3'-(3,6dioxaoctane-1,8-diiibis(sulfanodiyl))bis(1-(2,6,6trimethylcyclohex-1-, 2- o 3-en-l-yl)butan-l-one), 3,3'-(3,6dioxaoctano-1,8-diibis(sulfanodiyl))bis(1-(6-ethyl-2,6dimethylcyclohex-3-en-l-yl)butan-l-one), 3,3'- (3,6dioxaoctano-1,8-diibis(sulfanodiyl))bis(2-methi1-1-(2,6,6trimethylcyclohex-1-, 2- o 3-en-l-yl)butan-l-one), 3,3'-(3,6dioxaoctano-1,8-diibis(sulfanodiyl))bis(1-(2,6,6trimethylcyclohex-1,3-diene-1-yl)butan-l-one), 3,3'-(3,6,9, CRCznn / zznz / E / YiAi trioxundecane-1,11-diylbis(sulfanodiyl) )bis (1- (2,6,6trimethylcyclohex-1-, 2- or 3-en-l-yl)butan-l-ona) or 3,3'(3,6,9,12-tetraoxatetradecane-l,14diylbis(sulfanodiyl))bis(1-(2,6,6-trimethylcyclohex-l-, 2- or 3en-l-yl)butan-l-ona), 3,3'-(alkane-a,ω-diyldisulfonyl)bis(1(2,6,6-trimethylcyclohex-l-, 2- or 3-en-l-yl)butan-l-ona), 3,3'(alkane-α,ω-diyldisulfonyl)bis(1-(6-ethyl-2,6-dimethylcyclohex3-en-l-yl)butan-l-ona), 3,3'-(alkane-α,ωdiyldisulfonyl)bis(2-methyl-l-(2,6,6-trimethylcyclohex-l-, 2- or 3-en-l-yl) butan-l-ona) or a 3,3'-(alkane-a^diyldisulfonyl)bis(1-(2,6,6-trimethylcyclohex-1,3-dien-lyl)butan-l-ona), with the color of the alquilo group varying between C4 and C22, preferably between C4 and Cía, even more preferably between C5 and Cíe, tales like the 3,3'-(hexano-l,6diyldisulfonyl)bis(1-(2,6,6-trimethylcyclohex-l-, 2- or 3-en-lyl) butan-l-ona), 3,3'- (hexano-1,6-diyldisulfonyl)bis(1-(6ethyl1-2,6-dimethylcyclohex-3-en-1-yl)butan-l-ona), 3,3'(hexano-1,6-diyldisulfonyl)bis(2-methyl-l-(2,6,6trimethylcyclohex-1-, 2- o 3-en-l-yl)butan-l-one), 3,3'(hexano-1,6-diyldisulfonyl)bis(1-(2,6,6-trimethylcyclohex-1,3dien-l-yl)butan-l-one), 3,3'-(heptane-1,7diyldisulfonyl)bis(1-(2,6,6-trimethylcyclohex-1-, 2- o 3-en-lyl) butan-l-one), 3,3'- (octane-1,8-diyldisulfonyl)bis(1(2,6,6-trimethyldisulfonyl-c 3-en-l-yl)butan-l-one), 3,3'(nonano-1,9-diyldisulfonyl)bis(1-(2,6,6-trimethylcyclohex-l-, CRCznn / zznz / E / YiAi 2- or 3-en-l-yl)butan-l-ona), 3,3'-(decane-1,10diyldisulfonyl)bis(1-(2,6,6-trimethylcyclohex-1-, 2- or 3-en-lyl) butan-l-ona), 3,3'-(undecane-1,ll-diyldisulfonyl)bis(1(2,6,6-trimethylcyclohex-l-, 2- or 3-en-l-yl)butan-l-ona) or 3,3'(dodecane-1,12-diyldisulfonyl)bis(1-(2,6,6-trimethylcyclohex1-, 2- or 3-en-l-yl) butan-l-ona) or 3,3'-(oxaalkane-a,odiyldisulfonyl)bis(1-(2,6,6-trimethylcyclohex-1-, 2- or 3-en-lyl)butan-l-one), 3,3'-(oxaalkane-a,ω-diyldisulfonyl)bis(1-(6ethyl-2,6-dimethylcyclohex-3-en-1-yl)butan-l-one), 3,3'(oxaalkane-a,ω-diyldisulfonyl)bis(2-methyl-1-(2,6,6trimethylcyclohex-1-, 2- or 3-en-l-yl)butan-l-one) or a 3,3'(oxaalkane-a,ω-diyldisulfonyl)bis(1-(2,6,6-trimethylcyclohex1,3-dien-l-yl)butan-l-ona), with the range of the alquilo group that varies between C4y C22, preferably between C4y Cíe, and more preferably between C4y C12 and with alquilo group that includes one to four ether groups, such as 3,3' — (3 — oxapentane-1,5-diyldisulfonyl)bis(1-(2,6,6-trimethylcyclohex1-,2- o 3-en-l-yl)butan-l-one), 3,3'-(3,6-dioxaoctano-l,8diyldisulfonyl)bis(1-(2,6,6-trimethylcyclohex-l-, 2- o 3-en-yl )butan-l-one), 3,3'-(3,6-dioxaoctano-1,8diyldisulfonyl)bis(1-(6-ethyl-2,6-dimethylcyclohex-3-en-lyl)butan-l-one), 3,3'-(3,6-dioxaoctano-1,8diyldisulfonyl)bis(2-methyl-l-(2,6,6-trimethylcyclohex-l-, 2- o 3-en-l-yl)butan-l-one), 3,3'-(3,6-dioxaoctano-1,8diyldisulfonyl)bis(1-(2,6,6-trimethylcyclohex-l,3-diene-l, CRCznn / zznz / E / viAi i1)butan-l-one), 3,3'-(3,6,9-trioxaundecano-l, 11diyldisulfonyl)bis(1-(2,6,6-trimethylcyclohex-1-, 2- o 3-en-lyl)butan-l-one) 3,3'-(3,6,9,12-tetraoxatetradecano-l,14diyldisulfonyl)bis(1-(2,6,6-trimethylcyclohex-l-, 2- o 3-en-lyl)butano-l-one). In accordance with any embodiment of the invention, the compound of formula (I) is preferably a compound of formula R1 where R1, R2, R3 and Q indicated in formula (I), the compound of formula (I) is a have the same meaning, even more preferably, the compound of formula (if) CRCznn / zznz / E / YiAi where Q has the same meaning as indicated for the compound of formula (I). According to any of the above embodiments, the compound of formula (I) is a 4,4'-(alkanoa,ω-diylbis(sulfanediyl))bis(4-methylpentan-2-one) with the size of the alkyl group varying between C4 and C22, preferably between C4 and Cis, even more preferably between C5 and Cie, such as 4,4'-(hexane-1,6-diylbis(sulfanediyl))bis(4-methylpentan-2-one), 4,4'-(heptane-1,7-diylbis(sulfanediyl))bis(4-methylpentan-2-one), 4,4'-(octane-1,8-diylbis(sulfanediyl))bis(4-methylpentan-2-one), 4,4'-(nonane-1,9-diylbis(sulfanediyl))bis(4-methylpentan-2-one), 4,4'-(decane-1,10-diylbis(sulfanediyl))bis(4-methylpentan-2-one), 4,4'-(undecane-1,11-diylbis(sulfanediyl))bis(4-methylpentan-2-one) or 4,4'-(dodecane-1,12-diylbis(sulfanediyl))bis(4-methylpentan-2-one) or a 4,4'-(oxaalkane-a,ω-diylbis(sulfanediyl))bis(4-methylpentan-2-one) with the size of the alkyl group varying between C4 and C22, preferably between C4 and C6,even more preferably between C4 and C2 and with the alkyl group comprising one to four ether groups, such as 4,4'-(3-oxapentane-1,5-diylbis(sulfanediyl))bis(4-methylpentan-2-one), 4,4'-(3,6-dioxaoctane-1,8-diylbis(sulfanediyl))bis(4-methylpentan-2-one), 4,4'-(3,6,9-trioxaundecan-1,11-diylbis(sulfanediyl))bis(4-methylpentan-2-one) or 4,4'(3,6,9,12-tetraoxatetradecane-1,14-diylbis(sulfanediyl))bis(4-methylpentan-2-one). Compounds of formula (I) can slowly generate α,β-unsaturated aldehydes or ketones of formula (II) over time. Furthermore, as a side reaction, compounds according to formula (I), particularly if X is of formula (i), can generate thiols of formula (II'). In formulas (II) and (II'), each R1(') CRCznn / zznz / E / YiAi represents either R1 or R1', R2 1' > represents either R2 or R2' and R3<' > represents either R3 or R3', all with the same meaning as indicated in formula (I), and on the condition that within the same molecule of (II) or (II') all R1('>), R2d and R3 (') represent either R1, R2 or R3, or R1', R2' or R3'. RIO1C) ILIR^RK') (II) (IΓ) The compounds of formula (I) are non-volatile and essentially odorless. At the same time, they are relatively stable in perfume compositions or perfumed articles. When exposed to a surface under ambient conditions, it is believed that the compounds of (II) and / or (II') form through reaction with ambient moisture. The generation of these compounds can also be triggered by the presence of oxygen in the air, changes in pH, exposure to light, particularly UV-A light, the presence of enzymes, elevated temperatures, or other mechanisms, or a combination thereof. Non-volatile and essentially odorless compounds are advantageously characterized by a vapor pressure of less than 2.0 Pa, obtained by means of a calculation using the EPIwin v. 3.10 software (2000, available from the Agency of CRCznn / zznz / E / YiAi U.S. Environmental Protection). Preferably, the vapor pressure is less than 0.2 Pa, or even more preferably less than 0.02 Pa. Although it is not possible to provide an exhaustive list of the compounds of formula (II) or (II') that are generated from the compound of formula (I) of the invention, the following may be cited as preferred and non-limiting examples: (alpha-damascona), 1-(2,6,6trimethylcyclohex-l-en-l-yl)but-2-en-l-one (beta-damascona) , 1-(2,2-dimethyl-6-methylenecyclohexyl)but-2-en-l-one (gammadamascona), 1- (2,6,6-trimethylcyclohex-3-en-yl)but-2-en-canvas (delta-damascona) , 1-(6-ethyl-2,6-dimethylcyclohex-3-en-lyl)2-butene-l-one, 2-methyl-l-(2,6,6-trimethylcyclohex-2-en-lyl)but-2-en-l-one, 2-methyl-l-(2,6,6-trimethylcyclohex-l-en-lyl)but-2-en-l-one, 1- (2,2-dimethyl-6-hexyl) -2methylbut-2-en-l-one, 2-methyl-l-(2,6,6-trimethylcyclohex-3-en-lyl)but-2-en-l-one, 4- (2,6,6-trimethylcyclohex-2-en-l)but-3en-2-one (alpha-ionone), 4-(2,6,6-trimethylcyclohex-l-en-lyl)but-3-en-2-one (beta-ionone), 4-(2,2-dimethyl-6methylenecyclohexyl)but-3-en-2-one (gamma-ionone), 4-(2,6,6trimethylcyclohex-3-en-l-yl)but-3-en-2-one (delta-ionone), 1(2,6,6-trimethylcyclohex-l,3-yl-butonone) 1(2,2,3,6-trimethylcyclohexyl)but-2-en-l-one, 4-(2,2,3,6tetramethylcyclohexyl)but-3-en-2-one, 1-(5,5-dimethylcyclohex, 1-en-l-yl)pent-4-en-l-one, 3-methyl-5-propyl-2-cyclohexen-l-one, 3-mercapto-3-methyl-5-propylcyclohexan-l-one, 3methylcyclohex-2-en-l-one, 3-mercapto-3-methylcyclohexan-l-one, 3-methylcyclopent-2-en-l-one, 3-mercapto-3-methylcyclopentan-alone, 2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-l-ona (carvona), 5-methyl-2-(propan-2-ylidene)cyclohexan-1-ona (pulegona), 2—(2 — mercaptopropan-2-yl)-5-methylcyclohexan-l-ona, 1-(3,3-dimethyl1-cyclohexen-l-yl)-4-penten-l-ona, 1-(5-ethyl-5-methylcyclohex1-en-l-yl)pent-4-en-l-ona, 3,7-dimethylocta-2,6-dienal (citral), oct-2-en-4-ona, 2-mercaptooctane-4-ona, 5-methylhex-4en-3-ona, 5-mercapto-5-methylhexan-3-ona, 4-methylpent-3-en-2ona, 4-mercapto-4-methylpentan-2-ona, 3-methylpent-3-en-2-ona, 4-mercapto-3-methylpentan-2-ona, 3-methylbut-2-enal, 3mercapto-3-methylbutanal, but-2-enal or 3-mercaptobutanal y / o mezclas de los mismos. Compounds of formula (I) with X of formula (i) can be synthesized by the 1,4-addition reaction of a compound of formula HX-Q-XH with an α,β-unsaturated aldehyde or ketone of formula (II), where all symbols have the meanings indicated in formula (I). Compounds of formula (I) with X of structures (ii) or (iii) can then be obtained in a second step by (partial) oxidation of compounds of formula (I) with X of formula (i). Compounds of formula (I) can be prepared CRCznn / zznz / E / viAi using either one or two different α,β-unsaturated aldehydes or ketones of formula (II). If two different α,β-unsaturated aldehydes or ketones are used, compounds of formula (I) with different R1, R2, R3 and R1', R2', R3' groups are obtained. Preferably, only one α,β-unsaturated aldehyde or ketone of formula (II) is reacted with a compound of formula HX-Q-XH. Compounds of formula (I), with X of formula (i), can be synthesized from one molar equivalent of a compound of formula HX-Q-XH and two molar equivalents of one or more α,β-unsaturated aldehydes or ketones of formula (II). Alternatively, compounds of formula (I) can be synthesized from one molar equivalent of a compound of formula HX-Q-XH and less than two molar equivalents of one or more α,β-unsaturated aldehydes or ketones of formula (II). Preferably, compounds of formula (I) are synthesized using a slight molar excess of one or more α,β-unsaturated aldehydes or ketones of formula (II) with respect to the compound of formula HX-Q-XH. Preferably, 2.5 molar equivalents or more of one or more a,β-unsaturated aldehydes or ketones of formula (II) are used with respect to the compound of formula HX-Q-XH, more preferably 2.2 molar equivalents are used, even more preferably 2.1 molar equivalents. Therefore, the final compound of formula (I) may contain some compound(s). CACznn / zznz / E / YiAi remaining(s) of formula (II). The compounds of formula (I) with X of formula (i) can optionally be synthesized from a compound of formula HS-Q-SH and one or more α,β-unsaturated aldehydes or ketones of formula (II) in the presence of a base, which acts as a catalyst. Preferably, the base used for the transformation is 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU). The reaction can be carried out in the presence or absence of a solvent. Compounds of formula (I) with X of formula (ii) or (iii) are preferably prepared by oxidation of the corresponding compound of formula (I) with X of formula (i). For the preparation of compounds of formula (I) with X of formula (ii), Oxone (2 KHSO5 / KHSO4 / K2SO4) could be used as the oxidizing agent. Although it is not possible to provide an exhaustive list of compounds of the formula HX-Q-XH that may be used in the synthesis of the compounds of the invention, the following may be cited as preferred and non-limiting examples: 1,4-butanedithiol, 1,5-pentanedithiol, 1,6-hexanedithiol, 1,7-heptanedithiol, 1,8-octanedithiol, 1,9-nonanedithiol, 1,10-decanedithiol, 1,11-undecanedithiol, 1,12-dodecanedithiol, 1,5-dimercapto-3-oxapentane, 1,8-dimercapto-3,6-dioxaoctane, 1,11-dimercapto-3,6,9-trioxaundecane, or 1,14 CRCznn / zznz / E / YiAi dimercapto-3,6,9,12-tetraoxatetradecane. Although it is not possible to provide an exhaustive list of the compounds of formula (II) that may be used in the synthesis of the compounds of the invention, the following may be cited as preferred and non-limiting examples: 1-(2,6,6-trimethylcyclohex-l-en-lyl)but-2-en-l-one (beta-damascona) , 1-(2,2-dimethyl-6methylenciclohexyl)but-2-en-l-one (gamma-damascona), 1(2,6,6-trimethylcyclohex-3-en-1-yl)but-2-en-1-one (deltadamascona), 1-(6-ethyl-2,6-dimethylcyclohex-3-en-l-yl)2buten-l-one, 2-methyl-l-(2,6,6-trimethylcyclohex-2-en-lyl)but-2-en-l-one, 2-methyl-l-(2 , 6, 6-trimethylcyclohex-l-en1-yl)but-2-en-1-one, 1-(2,2-dimethyl-6-methylenecyclohexyl)-2methylbut-2-en-l-one, 2-methyl-l-(2,6,6-trimethylcyclohex-3en-l-yl)but-2-en-l-one, 3-methyl-4-(2,6,6-trimethyl-2cyclohexene-l-yl)-3-butene-2-one, 1-(2, 6, 6-trimethyl-2ciclohexen-l-yl)-l-penten-3-one, 4-(2,6,6-trimethylcyclohexen-2-but-en-3-en) (alpha-ionone), 4-(2,6,6trimethylcyclohex-1-en-l-yl)but-3-en-2-one (beta-ionone), 4(2,2-dimethyl-6-methyleneciclohexyl)but-3-en-2-one (gammaionone), 4-(2,6,6-trimethyIciclohex-3-en-yl)bution-en-2-one (delta-ion), 1-(2, 6, 6-trimethylcyclohex-l,3-diene-lyl)but-2-en-1-one, 1-(2,2,3, 6-tetramethylcyclohexyl)but-2en-l-one, 4-(2,2,3 , 6-tetramethylcyclohexyl-butene-, 1-3) CRCznn / zznz / E / YiAi (3,3- y 5,5-dimethylcyclohex-l-en-l-yl)pent-4-en-l-one, 3methyl-5-propyl-2-cyclohexen-l-one, 3-methylcyclohex-2-en-l-one, 3-methylciclohex-2-en-l-one, 2-methyl-5-(prop-l-en-2yl)cyclohex-2-en-l-one (carvona), 5-methyl-2-(propan-2ylidene)cyclohexan-1-one (pulegone), 1-(3,3-dimethyl-1cyclohexen-l-yl)-4-penten-l-one, 1-(5-ethyl-5-methylcyclohex1-en-1-yl)pent-4-en-1-one, 3,7-dimethylocta-2,6-dienal (nitrile), oct-2-en-4-one, 5-methylhex-4-en-3-one, 4methylpent-3-en-3-one, 2-meth-3-en-3-one 3-methylbut-2enal or but-2-enal. The a,β-unsaturated aldehydes or ketones of formula (II) generated from the compounds of formula (I) or used for the synthesis of the compounds of formula (I) may be in the form (E), or in the form (Z), or in mixtures thereof. The compounds of formula (I) can be obtained and used as a mixture of several different compounds of formula (I) and / or as a mixture with one or more compounds of formula (II), or can be further purified according to standard methods known to persons skilled in the art. The mixtures of compounds (I) and (II) comprise at least 70% of compound (I), preferably more than 80% of compound (I), more preferably more than 90% of compound (I), and even more preferably more than 95% of compound (I). CRCznn / zznz / E / YiAi CRCznn / zznz / E / YiAi Compounds of formula (I) can also be obtained and used in a mixture with a compound of formula R1XVXH,M(III) O KK which is also part of the present invention, and wherein all the symbols have the same meaning as indicated in formula (I). The mixtures of compounds (I) and (III) comprise at least 30% of compound (I), preferably more than 50% of compound (I), more preferably more than 75% of compound (I), even more preferably more than 90% of compound (I), and still more preferably more than 95% of compound (I). As mentioned above, the invention relates to the use of a compound of formula (I) as a fragrance ingredient to provide a long-lasting scent, particularly a floral and fruity scent, to the environment. In other words, it relates to a method for imparting, enhancing, improving, or modifying the scent, particularly a floral and fruity scent, of a fragrance composition or a perfumed article. This method comprises adding to the composition or article an effective amount of at least one compound of formula (I). The use of a compound of formula (I) herein also includes the use of any composition containing a compound of formula (I) that can be advantageously employed in the perfume industry. A fragrance ingredient is understood here to be a compound used in a fragrance composition or preparation to impart a hedonic effect. In other words, for such a fragrance ingredient to be considered as a fragrance, it must be recognized by a person skilled in the art as capable of imparting or modifying the scent of a composition in a positive or pleasant way, and not merely as one that has a scent. The expression "floral and fruity scent" or "floral and fruity note" should be understood as a scent reminiscent of a floral olfactory impression, such as roses, and a fruity one, particularly red berry notes, such as raspberry or strawberry, fruity-floral notes such as blackcurrant, blackcurrant, and exotic fruit notes. Fresh scents can be associated with fruity and floral notes, but also with citrus and green undertones, with green scents reminiscent, for example, of freshly cut grass. Fresh green scents can also have herbaceous and minty undertones. For the sake of clarity, a long-lasting effect is typically achieved if, after a certain time, for example, after several hours or days, a given compound CACznn / zznz / E / YiAi emits a greater amount of odor into the environment than a reference compound that provides the same type of odor. Accordingly, the expression "long-lasting floral and fruity notes" when referring to the compound of formula (I) of the invention should be understood as an increase in the duration of the perception of the floral and fruity odor (release of compounds into the atmosphere that provides a floral and fruity olfactory impression) compared to that of the molecules that have such an impression alone, and measured under the same conditions, for example, after several hours (6 or 8 hours) or days (1 or 3 days). The compositions, which can in fact be advantageously used as perfume ingredients, are also an object of the present invention. Therefore, another aspect of the present invention is a perfume composition comprising: i) as a perfume ingredient, at least one compound of the invention as defined above; ii) at least one ingredient selected from the group consisting of a perfume carrier and a perfume base; and iii) optionally at least one perfume adjuvant. By perfume carrier is meant here a material that is practically neutral from the point of view CRCznn / zznz / E / YiAi of perfumery, meaning that it does not significantly alter the organoleptic properties of the fragrance ingredients. The carrier can be a liquid or a solid. A perfume carrier is defined here as a material that is practically neutral from a perfumery standpoint, meaning that it does not significantly alter the organoleptic properties of the fragrance ingredients. The carrier can be a liquid or a solid. Examples of liquid carriers that can be used include, but are not limited to, an emulsifying system (i.e., a solvent and a surfactant system) or a solvent commonly used in perfumery. A detailed description of the nature and types of solvents commonly used in perfumery cannot be exhaustive. However, examples that are not limited to include solvents such as butylene or propylene glycol, glycerol, dipropylene glycol and its monoether, 1,2,3-propanetriyl triacetate, dimethyl glutarate, dimethyl adipate, 1,3-diacetyloxypropan-2-yl acetate, diethyl phthalate, isopropyl myristate, benzyl benzoate, benzyl alcohol, 2-(2-ethoxyethoxy)-1-ethane, triethyl citrate, or mixtures thereof, which are the most commonly used. For compositions comprising both a perfume carrier and a perfume base, other suitable perfume carriers in addition to those specified above, CRCznn / zznz / E / YiAi may also be ethanol, water / ethanol mixtures, limonene or other terpenes, isoparaffins such as those known under the trade name Isopar® (origin: Exxon Chemical) or glycol ethers and glycol ether esters such as those known under the trade name Dowanol® (origin: Dow Chemical Company), or hydrogenated castor oils such as those known under the trade name Cremophor® RH 40 (origin: BASF). The term "solid carrier" is proposed to designate a material to which the fragrance composition, or some element thereof, can be chemically or physically bound. Generally, such solid carriers are employed either to stabilize the composition or to control the evaporation rate of the composition or of certain ingredients. The use of a solid carrier is standard practice in the art, and a person skilled in the art knows how to achieve the desired effect. However, by way of non-limiting examples of solid carriers, one could cite absorbent gums or polymers, or inorganic materials such as porous polymers, cyclodextrins, wood-based materials, organic or inorganic gels, clays, gypsum, talc, or zeolites. As other non-limiting examples of solid carriers, encapsulation materials can be cited. Examples of such materials may include materials CRCznn / zznz / E / YiAi wall formers and plasticizers, such as mono, di or trisaccharides, natural or modified starches, hydrocolloids, cellulose derivatives, polyvinyl acetates, polyvinyl alcohols, proteins or pectins, or even the materials cited in reference texts such as H. Scherz, Hydrokollide: Stabilisatoren, Dickungs- und Geliermittel in Lebensmitteln, Band 2 der Schriftenreihe Lebensmittelchemie, Lebensmittelqualitát, Behr's Verlag GmbH & Co., Hamburg, 1996. Encapsulation is a process well known to a person skilled in the art, and can be carried out, for example, using techniques such as spray drying, agglomeration or even extrusion; or consists of a coating encapsulation, including the coacervation technique and complex coacervation. As non-limiting examples of solid carriers, one can cite in particular core-coated capsules with resins of the aminoplast, polyamide, polyester, polyurea or polyurethane type or a mixture thereof (all of the resins are well known to a person skilled in the art) using techniques such as polymerization-induced phase separation, interfacial polymerization, coacervation or all of them together (all of the techniques have been described in the previous art), optionally in the presence of a polymeric stabilizer or a cationic copolymer. CACznn / zznz / E / YiAi The resins can be produced by the polycondensation of an aldehyde (e.g., formaldehyde, 2,2-dimethoxyethanal, glyoxal, glyoxylic acid, or glycolaldehyde, and mixtures thereof) with an amine such as urea, benzoguanamine, glycoluril, melamine, methylol melamine, methylated methylol melamine, guanazole, and the like, as well as mixtures thereof. Alternatively, preformed alkylated polyamine resins such as those commercially available under the brand names Urac® (origin: Cytec Technology Corp.), Cy mel® (origin: Cytec Technology Corp.), Urecoll®, or Luracoll® (origin: BASF) can be used. Other resins are those produced by the polycondensation of a polyol, such as glycerol, and a polyisocyanate, such as a hexamethylene diisocyanate trimer, an isophorone diisocyanate trimer or xylylene diisocyanate, or a hexamethylene diisocyanate biuret, or a xylylene diisocyanate trimer with trimethylolpropane (known by the trade name Takenate®, origin: Mitsui Chemicals), among which are a xylylene diisocyanate trimer with trimethylolpropane and a hexamethylene diisocyanate biuret. Part of the fundamental literature related to the encapsulation of perfumes by the polycondensation of amino resins, mainly melamine-based resins with aldehydes, includes that represented by articles such as CRCznn / zznz / E / viAi, such as those published by K. Dietrich et al. in Acta Polymerica, 1989, vol. 40, pages 243, 325, and 683, as well as 1990, vol. 41, page 91. These articles already describe the various parameters affecting the preparation of such core-shell microcapsules following prior art methods, which are also further detailed and exemplified in the patent literature. US 4,396,670, in favor of Wiggins Teape Group Limited, is a relevant early example of the latter. Since then, many other authors have enriched the literature in this field, and it would be impossible to cover all published developments here, but the general knowledge in encapsulation technology is very significant. The most recent relevant publications, describing the appropriate uses of such microcapsules, are represented, for example, by the article by K. Bruyninckx and M. Dusselier, ACS Sustainable Chemistry & Engineering, 2019, vol. 7, pages 8041-8054. A perfumery base is understood here to be a composition comprising at least one perfume co-ingredient. The co-fragrance ingredient is not of formula (I). Furthermore, by co-fragrance ingredient is meant herein a compound used in a fragrance composition or preparation in addition to the fragrance ingredient of formula (I), and which imparts, just as the fragrance ingredient of formula (I) does, fragrance. CRCznn / zznz / E / YiAi (I), a hedonic effect. In other words, such a co-ingredient, to be considered a perfumer, must be recognized by a person skilled in the technique as capable of imparting or modifying in a positive or pleasant way the smell of a composition, and not just as one that has a smell. In particular, the perfume co-ingredients that could be used in a perfume composition or preparation according to the invention include, but are not limited to, the following non-limiting examples: a) natural or nature-identical ingredients and natural extracts, preferably those obtained from red fruits, such as strawberries or raspberries; b) Ingredients with strawberry notes, such as oct-2-en-4-one, 2,5-dimethyl-4-hydroxy-2H-furan-3-one (Furaneol®), 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone, 2,5-dimethyl-4-oxo-4,5-dihydrofuran-3-yl acetate, ethyl 3-methyl-3-phenyloxyran-2-carboxylate (Strawberry Puré®), ethyl 3-phenyloxyran-2-carboxylate, methyl 2-acetamidobenzoate or 3-phenylpropyl 3-methylbutanoate, 2-methyl-4-oxo-4H-pyran-3-yl propionate, 2-methylpent-2-enoic acid or (2S,5S)-2-(tert-butyl)-5-methyl-2-propyltetrahydrofuran (Dihydrocassyrane®) ; c) ingredients with raspberry notes, such as 4-(4-methoxyphenyl)butan-2-one (raspberry ketone); d) ingredients with other fruity notes, such as ethyl butyrate, ethyl 2-methylbutanoate, 2-methyl CRCznn / zznz / E / YiAi ethyl pentanoate, gamma-nonalactone, gamma-undecalactone, hexilate acetate, aliphatic heptanoate, aliphatic 3-cyclohexylpropanoate, 2-phenoxyethyl isobutyrate, 2,2,5-trimethyl-5-pentylcyclopentanoate, 2-methyl-4-propyl-1,3-oxatianoate, 4-decanol, 5-heptyldihydrofuran-2(3H)-one, 3-methyl-2-hexen-1-yl acetate, 1-(3,3dimethylcyclohexyl)ethyl (3-ethyl-2-oxiranyl)acetate, 2-(2-methyl-1,3-dioxolan-2-yl)ethyl acetate (Fructone®) or diethyl cyclohexane-1,4-dicarboxylate (Fructalate®); e) ingredients with caramel notes, such as 2-ethyl-3-hidroxi-4H-pyran-4-one; f) ingredients with citric notes, such as 1methyl-4-(1-methylethenyl)-cyclohexeno (limoneno), 2,6-dimethyl7-octen-2-ol (dihidromyrcenol), 1,5-dimethyl-lvinyl-4-hexenyl acetate (linalyl acetate), 3,7-dimethyl-6octenonitrile, acetate lp-menten-8-ilo ol,4(8)-pmentadiene; g) ingredients with citrus floral notes, such as methyl 2-(3-oxo-2-pentylcyclopentyl)acetate (Hedione®); h) Ingredients with floral notes, such as 3,7-dimethylocta-1,6-dien-3-ol (linalool), 3,7-dimethyl-3-octanol, 3,7-dimethyl-6-octen-1-ol (citronellol), 3,7-dimethyl-2,6-octadien-1-ol (geraniol, nerol), 2-phenylethanol, 3-methylbutyl 2-hydroxybenzoate, 2-hydroxybenzoate CRCznn / zznz / E / YiAi pentyl, 1-(6-ethyl-2,6-dimethylcyclohex-3-en-l-yl)2-buten-ionic acid, 2-hydroxybenzoate hexilo, 2-hydroxybenzoate benzyl or 2-hydroxybenzoate cyclohexilo, 3-(4-tert-butylphenyl)-2methylpropanal, 2-pentyl-3-phenyl-2-propenal, 2-hexyl-3-phenyl2-propenal, benzyl acetate, tetrahydro-2-isobutyl-4-methyl4 (2H)-pyranol, 2-(methylamino)benzoate methyl, 2,5-dimethyl2-indanmethanol, 2,6,6-trimethyl-3-cyclohexeno-l-carboxylate, 3- ( 4,4-dimethyl-1-cyclohexen-1-yl)propanal, 3,7-dimethyl-1,6nonadien-3-ol, 3-(4-isopropylphenyl)-2-methylpropanal, tricyclo[5.2.1.0(2,6)]dec-3- y 4-en-8-yl propionate tricyclo[5.2.1.0(2,6)]dec-3- y 4-en-8-yl, 2-methylpropanoate de tricyclo [ 5.2.1.0(2,6) ]dec-3- y 4-en-8-ilo, p-ment-l-en-8ol, acetato de 4-(1,1-dimethylethyl)-1-cyclohexilo, acetato de 1,l-dimethyl-2-phenyletilo, acetato de 3,7-dimethyl-2,6octadienilo, acetato de 7-metiloctilo, acetato de 4-(1,1-dimethylethyl)-1-cyclohexilo, 4-cyclohexyl-2-methyl-2-butanol, 3-methyl-5-phenyl-l-pentanol, cis-7-p-mentanol, (3)-2-(1,1-dimethylpropoxy)propanol, 2-metoxinaftaleno, acetato de 2,2,2-trichloro-l-feniletilo, 4 / 3-(4-hidroxi-4metilpentil)-3-ciclohexeno-l-carbaldehido, 8-decen-5-olida o 4-fenil-2-butanona;. i) ingredients with sweet floral notes, such as 1-(octahidro-2,3,8,8-tetrame-2-naphthalenil)-1-ethanone (Iso E Super®, mixture of isomers); j) ingredients with green notes, tales like el (Z) CRCznn / zznz / E / YiAi hex-3-en-l-ol, acetato de (Z)-hex-3-en-l-ilo, butirato de (Z)-hex-3-en-l-ilo, benzoato de (Z)-hex-3-en-l-ilo, 2hidroxibenzoato de (Z)-hex-3-en-l-ilo, 2-metil-3-hexanona (E)oxime, 2,4-dimetil-3-ciclohexeno-l-carbaldehído, acetato de 2terc-butil-l-ciclohexilo, acetato de 1-feniletilo, (2metilbutoxi)acetato de aillo, 4-metil-3-decen-5-ol o éter difenilico; k) ingredients with almizcladas notes, such as 1, 4-dioxa-5,17-cycloheptadecanodione, (Z)-4-cyclopentadecen1-one, (9Z)-9-cycloheptadecen-l-one, 2-{lS)-l[(IR)-3,3-dimethylcyclohexyl]ethoxy}-2-oxoethyl propionate, 3-methyl-5cyclopentadecen-l-ona, [1-(3',3'-dimethyl-1'cyclohexyl)ethoxycarbonyl]methyl propanoate, 1,3,4,6,7,8-hexahydro- 4,6,6,7,8,8-hexamethyl-cyclopenta-g-2-benzopyran, oxacyclohexadecan-2-one (Exaltolide®), oxacyclohexadec-12- and / or 13-en-2-one (Habanolide®), 3-methylcyclopentadecan-l-one (Muscone®), (Z)-3-methylcyclopentadec-5-en-1-one (Muscenone®) or 2-(1-(3,3-dimethylcyclohexyl)ethoxy)-2methylpropyl propionate (Helvetolide®). In an alternative embodiment, the perfume co-ingredients that could be used in a perfume composition or preparation according to the invention include, but are not limited to, 1-(2,6,6-trimethylcyclohex-2-en-1-yl)but-2-en-l-one (alpha-damascone), 1-(2,6,6-trimethylcyclohex-1-en-l-yl)but-2-en-l-one (beta-damascone), CRCznn / zznz / E / YiAi 1-(2,2-dimethyl-6-methylenecyclohexyl) but-2-en-l-one (gainmadamascona), 1- (2,6,6-trimethylcyclohex-3-en-l-yl)but-2-en-lone (delta-damascona), 2-methyl-l-(2,6,6-trimethylcyclohex-2en-l-yl)but-2-en-l-one, 2-methi1-1-(2,6,6-trimethylcyclohex-len-l-yl)but-2-en-l-one, 1- (2,2-dimethyl-6-methylenecyclohexyl)2-methylbut-2-en-l-one, 2-methyl-l-(2,6,6-trimethylciclohex-3en-l-yl)but-2-en-l-one, 3-methyl-4-(2,6,6-trimethyl-2ciclohele-x-3-en-l-one, 1-(2,6,6-trimethyl-2cyclohexene-l-yl)-l-penten-3-one, 4- (2,6,6-trimethylcyclohex-2en-l-yl)but-3-en-2-one (alpha-ionone), 4-(2,6,6-trimethylcyclohexen-1-yl-butyl-3-en) (beta-ionone), 4(2,2-dimethyl-6-methylenecyclohexyl)but-3-en-2-one (gammaionone), 4- (2,6,6-trimethylcyclohex-3-en-l)but-3-en-2-one (delta-ionone), 1-(2,6,6-trimethylcyclohex-l,3-dien-l-yl)but2-en-l-one, 1-(2,2,3,6-tetramethylcyclohexyl)but-2-en-l-one, 4-(2,2,3,6-tetramethylcyclohexyl)but-3-en-1(3,3-y 5,5dimethylcyclohexen-l-en-yl)pent-4-en-l-one, 3-methyl-5-propyl2-cyclohexen-l-one,3-mercapto-3-methyl-5-propylcyclohexan-one, 3-methylcyclohex-2-en-l-one, 3-mercapto-3methylcyclohexan-l-one, 3-methylcyclopent-2-en-l-one, 3-mercapto-3-methylcyclopentane, 2-methyl-5-(prop-l-en-2yl)cyclohex-2-en-l-one (carvona), 5-methyl-2-(propan-2ylidene)cyclohexan-1-one (pulegone), 2-(2-mercaptopropane-2yl)-5-methylcyclohexane, 1-l-(3, 3-dimethyl-l-cyclohexene-lyl)-4-penten-l-one, 1-(5-ethyl-5-methylcyclohex-l-en-l-yl)pent, CRCznn / zznz / E / YiAi 4-en-l-one, 3,7-dimethyloct-2,6-dienal (citral), oct-2-en-4one, 2-mercaptooctane-4-one, 5-methylhex-4-en-3-one, 5-mercapto5-methylhexan-3-one, 4-methylpent-3-one, 4-mercapto-4methylpentan-2-one, 3-methylpent-3-en-2-one, 4-mercapto-3methylpentane-2-one, 3-methylbut-2-enal, 3-mercapto-3methylbutanal, but-2-enal or 3-mercaptobutanal. Furthermore, a person skilled in the technique is able to select other fragrance co-ingredients based on general knowledge and according to the intended use or application and the desired organoleptic effect. The nature and type of these other fragrance co-ingredients do not warrant a more detailed description here, which in any case would not be exhaustive. Generally speaking, these fragrance co-ingredients belong to chemical classes as varied as alcohols, lactones, aldehydes, ketones, esters, ethers, acetates, nitriles, terpenoids, nitrogenous or sulfurous heterocyclic compounds, and essential oils, and fragrance co-ingredients can be of natural or synthetic origin. In any case, many of these co-ingredients are listed in reference texts such as S. Arctander's book, Perfume and Flavour Chemicals, 1969, Montclair, New Jersey, USA.or its more recent versions, or in other works of a similar nature, as well as in the abundant patent literature in the field of perfumery. It is also understood that. CRCznn / zznz / E / YiAi Co-ingredients can also be compounds known to release various types of perfume compounds in a controlled manner, or they can be an encapsulated perfume. The term perfumery adjuvant refers to an ingredient that can impart an additional benefit, such as color, lightfastness, chemical stability, etc. A detailed description of the nature and type of adjuvant commonly used in perfume bases cannot be exhaustive, but it should be noted that these ingredients are well known to someone skilled in the craft.However, the following can be cited as specific, non-limiting examples: viscosity agents (e.g., surfactants, thickeners, gelling agents and / or rheology modifiers), stabilizing agents (e.g., preservatives, antioxidants, heat / light and / or buffer solutions or chelating agents, such as BHT), coloring agents (e.g., dyes and / or pigments), preservatives (e.g., antibacterial or antimicrobial or antifungal or antiirritant agents), abrasives, skin cooling agents, fixatives, insect repellents, ointments, vitamins and mixtures thereof. It is understood that a person expert in the technique is perfectly capable of designing optimal formulations for the desired effect by mixing the aforementioned components. CRCznn / zznz / E / YiAi previously of a perfume composition, simply by applying standard knowledge of the technique as well as through trial and error methodologies. Other suitable perfumery adjuvants optionally used in combination with the compounds according to the present invention comprise tertiary amines, in particular those with high water solubility, such as triethanolamine, methyldiethanolamine, dimethylethanolamine, alkyldiethanolamines and ethoxylated alkyldiethanolamines. A particular aspect of the perfumery compositions of the invention relates to those that also optionally comprise (in addition to the compositions mentioned above) at least one compound selected from the isothiazolones of the formula EITHER R5 CRCznn / zznz / E / viAi where R4 and R5 represent, separately and independently of each other, a hydrogen atom, a halogen atom, preferably chlorine, a linear or branched C1-C4 alkyl group, an amino group, or a benzylamino group; or, alternatively, R4 and R5 are taken together to represent a phenyl or pyridine ring, possibly substituted with one to four linear or branched C1-C4 alkyl or alkenyl groups and / or one to two halogen atoms, preferably chlorine atoms; and R6 represents a hydrogen atom, an alkali metal atom, in particular Na or K, a phenyl or benzyl group possibly substituted with one or two halogen atoms and / or one or two methyl, trifluoromethyl, methoxy or amino groups, an amine group, or an unsaturated linear, branched or cyclic Ci-Cs hydrocarbon group possibly substituted with one or two nitrogen, oxygen or halogen atoms. According to a particular embodiment of the invention, the compound of formula (IV) is that in which R4 and R5 represent, separately and independently of each other, a hydrogen atom, a chlorine atom or a methyl group or, alternatively, R4 and R5 are taken together to represent a phenyl ring, and R6 represents a hydrogen atom or a methyl group. According to a particular embodiment of the invention, the compound of formula (IV) is selected from the group of isothiazolones consisting of 1,2-benzisothiazol-3(2H)-one, 4- or 5-chloro-2-methylisothiazol-3(2H)-one or 2-methylisothiazol-3(2H)-one, or more preferably 5-chloro-2-methylisothiazol-3(2H)-one or 1,2-benzisothiazol-3(2H)-one, and even more preferably 1,2-benzisothiazol-3(2H)-one. According to a particular modality of the In the CACznn / zznz / E / YiAi invention, the compound of formula (IV) is present in the compositions of the invention at a weight concentration of 0.0% to 5%, with respect to the total weight of the composition. According to the most preferred embodiments of the invention, the concentration of the compound of formula (IV) is between 0.001 and 3% of the total weight, preferably between 0.005 and 0.1%. A composition of the invention consisting of at least one compound of formula (I) and at least one perfume carrier represents a particular embodiment of the invention, as well as a perfume composition comprising at least one compound of formula (I), at least one perfume carrier, at least one perfume base, and optionally at least one perfume adjuvant. It is useful to mention here that it is important to have the possibility, in the compositions mentioned above, of using in addition to a compound of formula (I) other compounds of similar or different nature that are capable of generating other fragrances, since this allows the perfumer to prepare accords, perfumes, that possess the scent tone of several compounds of the invention, thus creating a new building block for the purposes of creation. For the sake of clarity, it is also understood that any mixture resulting directly from a chemical synthesis, for example, a reaction medium without purification CRCznn / zznz / E / YiAi, in which the compound of the invention could be involved as a starting, intermediate, or final product, cannot be considered a perfume composition according to the invention because the mixture does not provide the compound of the invention in a form suitable for perfumery. Accordingly, unpurified reaction mixtures are generally excluded from the present invention unless otherwise specified. Furthermore, the compound of formula (I) of the invention can also be advantageously used in all fields of modern perfumery, i.e., fine or functional perfumery, to positively impart a long-lasting or substantive strawberry scent to a consumer product in which the compound (I) is added. Accordingly, another aspect of the present invention relates to a perfumed consumer product comprising, as a perfumed ingredient, at least one compound of formula (I) or a perfumed composition, as defined above. The compound of the invention can be added as such or as part of a perfume composition of the invention. For the sake of clarity, it should be mentioned that a perfumed consumer product is defined as a consumer product that is expected to provide at least a pleasant fragrance effect to the surface to which it is applied (for CRCznn / zznz / E / YiAi (e.g., skin, hair, fabrics, or hard surfaces). In other words, a scented consumer product according to the invention is a scented consumer product comprising the functional formulation, as well as optionally additional beneficial agents, corresponding to the desired consumer product, for example, a conditioner, a detergent, or an air freshener, and an olfactorily effective amount of at least one compound of the invention. For clarity, the scented consumer product is a non-edible product. The nature and type of constituents of the perfumed consumer product do not justify a more detailed description here, which in any case might not be exhaustive; the person expert in the technique is able to select them based on their general knowledge and in accordance with the nature and desired effect of the product. As used in this document, consumer product refers to baby care, personal care, fabric and home care, family care, feminine care, health care, beauty care and the like, generally proposed to be used or consumed in the form in which they are sold. Non-limiting examples of suitable perfumed consumer products may include a perfume, such as a fine perfume, a cologne, or an after-sun lotion CACznn / zznz / E / YiAi shaving; a fabric care product, such as a liquid or solid detergent or a single-dose detergent (such as a powder tablet, a single-dose liquid detergent, or a single-dose multi-chamber detergent), a fabric softener, a fabric refresher, ironing water, paper, bleach, carpet cleaner, or a curtain care product;a body care product, such as a hair care product (e.g., shampoo, hair coloring preparation or spray, color care product or hair styling product), a dental care product, a disinfectant, an intimate care product), a cosmetic preparation (e.g., a skin cream or lotion, a vanishing cream or a deodorant or antiperspirant (e.g., a spray or a roll-on device), a hair remover, a tanning lotion, a sun protection or after-sun product, a nail product, a skin cleansing product or makeup), a skin care product (e.g., a perfumed soap, a shower or bath foam, an oil or gel, a hygiene product or a foot / hand care product);an air care product, such as an air freshener or a ready-to-use powder air freshener, which can be used in the home space; CRCznn / zznz / E / YiAi (rooms, refrigerators, closets, shoes or cars) and / or in a public space (hallways, hotels, shopping malls, etc.); or a household care product such as a mold remover, furniture care product, wipe, dish soap or hard surface cleaner (e.g., floor, bathroom, toilet or windows), leather care product; an automotive care product such as polish, wax or plastic cleaner. The preferred scented compositions or perfumed items are perfumes, detergents for fabrics or hard surfaces, hair care products, and fabric softeners or refreshers. Typical examples of detergents or fabric softeners into which the compounds of the invention may be incorporated are described in WO 97 / 34986, or in US Patents 4,137,180 and 5,236,615 or in EP 799,885. Other typical detergents and fabric softeners that may be used are described in works such as Ullmann's Encyclopedia of Industrial Chemistry, vol. 20, WileyVCH, Weinheim, pp. 355-540 (2012); Flick, Advanced Cleaning Product Formulations, Noye Publication, Park Ridge, New Jersey (1989); Showell, in Surfactant Science Series, vol. 71: Powdered Detergents, Marcel Dekker, New York (1988); Proceedings of the World Conference on Detergents (4 / a., 1998, CRCznn / zznz / E / YiAi Montreux, Switzerland), AOCS print. Some of the consumer product bases mentioned above may represent an aggressive environment for the compound of the invention, so it may be necessary to protect the latter from premature decomposition, for example, by means of encapsulation or by means of chemical bonding to another chemical product that is suitable to release the ingredient of the invention upon a suitable external stimulus, such as an enzyme, light, heat, oxidation or a change in pH. The proportions in which the compounds according to the invention can be incorporated into the various articles or compositions mentioned above vary within a wide range of values. These values depend on the nature of the article to be perfumed and the desired organoleptic effect, as well as on the nature of the co-ingredients in a given base when the compounds according to the invention are mixed with perfume co-ingredients, solvents, or additives commonly used in the art. For example, in the case of fragrance compositions, typical concentrations are on the order of 0.001% to 10% by weight, or even more, of the compounds of the invention based on the weight of the composition into which they are incorporated. Concentrations lower than these, such as CRCznn / zznz / E / YiAi those of the order of 0.01% to 2 or 5% by weight, can be used when these compounds are incorporated into perfumed articles, the percentage is relative to the weight of the article. As mentioned above, the invention relates to a method for imparting a long-lasting or substantial floral and fruity scent to surfaces, such as hard surfaces, fabrics, skin, or hair. Perfume ingredients that provide a floral and fruity scent to the environment through evaporation from a surface are typically not very long-lasting or substantial. As described above, one reason for this is their relatively high volatility, which ensures efficient evaporation after deposition on the surface. Another reason is that very often only small amounts of these compounds are efficiently deposited on the surface. This is particularly true if they are applied to a surface by means of perfume compositions or perfumed articles, which are rinsed off after application.This rinsing stage also removes a significant amount of the perfume, which is intended to remain on the target surface. Examples of this include washing and cleaning agents such as hard surface cleaners, detergents, shower gels, shampoos, and similar products, which are rinsed off after application. Furthermore, perfuming a surface by placing it in contact with the fragrance compositions or perfumed articles, from which the perfume is deposited onto the surface through a distribution equilibrium between the compositions or perfumed articles and the surface itself, may be inefficient. Examples of this include surface conditioners or refreshers, such as fragrance softeners, which are applied to the target and then rinsed off or allowed to dry.The compounds of formula (I) according to the present invention are suitable for enhancing the deposition of perfume and thus imparting a long-lasting floral and fruity scent to surfaces, such as hard surfaces, fabrics, skin, or hair. Therefore, another aspect of the present invention relates to a method for imparting a long-lasting or substantive fruity and floral odor to surfaces, such as hard surfaces, fabrics, skin, or hair, by adding at least one compound of formula (I) to perfume compositions or perfumed articles and applying them to the corresponding target surface. The present invention also relates to a microcapsule comprising at least one compound of formula (I). In one embodiment, at least one compound of formula (I) is encapsulated in a core-shell microcapsule in which CRCznn / zznz / E / viAi At least one compound of formula (I) is contained in the core surrounded by the shell. In one embodiment, the microcapsule shell protects the compound of formula (I) from the environment. The shell is made of a material capable of releasing at least one compound of formula (I). In one embodiment, the shell is made of a material capable of releasing the compound of formula (I) upon rupture of the shell and / or by diffusion through the shell. A person skilled in the art is well acquainted with the processes for preparing the microcapsules. The nature of the polymeric coating of the microcapsules of the invention may vary. As non-limiting examples, the coating may be aminoplast-based, polyamide-based, polyester-based, polyurea-based, or polyurethane-based. According to one modality, the coating is a biopolymer-based coating comprising a protein. The coating can also be a hybrid, specifically organic-inorganic, such as a hybrid coating composed of at least two types of inorganic particles that are crosslinked, or even a coating that results from the hydrolysis and condensation reaction of a polyalkoxysilane macromonomeric composition. According to one embodiment, the coating comprises an aminoplast copolymer, such as melamine-formaldehyde. CRCznn / zznz / E / viAi or urea-formaldehyde or cross-linked formaldehyde melanin or glyoxal melanin. According to another modality, the microcapsules have a polymeric coating that results from a complex coacervation where the coating is possibly cross-linked. According to another embodiment, the polyurea-based shell is made of, for example, but not limited to, isocyanate-based monomers and amine-containing crosslinkers such as guanidine carbonate and / or guanazole. Preferred polyurea microcapsules comprise a polyurea wall that is the polymerization product of at least one polyisocyanate comprising at least two isocyanate functional groups and at least one reagent selected from the group consisting of an amine (for example, a water-soluble guanidine salt and guanidine); a colloidal stabilizer or emulsifier; and an encapsulated perfume. However, the use of an amine is optional. According to one particular embodiment, the colloidal stabilizer includes an aqueous solution of between 0.1% and 0.4% polyvinyl alcohol, between 0.6% and 1% of a cationic vinylpyrrolidone copolymer, and a quaternized vinylimidazole (all percentages are defined by weight relative to the total weight of the colloidal stabilizer). According to another embodiment, the emulsifier is a biopolymer. CRCznn / zznz / E / YiAi anionic or amphiphilic preferably selected from the group consisting of gum arabic, soy protein, gelatin, sodium caseinate and / or mixtures thereof. The preparation of an aqueous dispersion / suspension of core-shell microcapsules is well known to a person skilled in the art. In one respect, the microcapsule wall material can comprise any suitable resin and especially includes melamine, glyoxal, polyurea, polyurethane, polyamide, polyester, etc. Suitable resins include the reaction product of an aldehyde and an amine; suitable aldehydes include formaldehyde and glyoxal. Suitable amines include melamine, urea, benzoguanamine, glycoluril, and mixtures thereof. Suitable melamines include methyl melamine, methylated methyl melamine, imino melamine, and mixtures thereof. Suitable ureas include dimethyl urea, methylated dimethyl urea, urea-resorcinol, and mixtures thereof. Suitable materials for manufacturing can be obtained from one or more of the following companies: Solutia Inc. (St. Louis, Missouri, USA)), Cytec Industries (West Paterson, New Jersey, USA), Sigma-Aldrich (St. Louis, Missouri, USA). According to one particular formulation, the core-shell microcapsule is a formaldehyde-free capsule. A typical process for preparing the formaldehyde-free aminoplast microcapsule suspension CRCznn / zznz / E / YiAi comprises the steps of 1) preparing an oligomeric composition comprising the reaction product of, or which can be obtained by reacting together a) a polyamine component in the form of melamine or a mixture of melamine and at least one C1-C4 compound comprising two NH2 functional groups; (b) an aldehyde component in the form of a mixture of glyoxal, a C4-6 2,2-dialkoxyethanal and optionally a glyoxalate, the mixture having a molar ratio of glyoxal / C4-6 2,2-dialkoxyethanal of between 1 / 1 and 10 / 1; and c) a protic acid catalyst; 2) preparing an oil-in-water dispersion, wherein the droplet size is between 1 and 600 pm, and comprising: i. an oil; ii. an aqueous medium iii. at least one oligomeric composition such as that obtained in step 1; iv. at least one crosslinking agent selected from A) aromatic or aliphatic C4-C12 di- or triisocyanates and their biurets, triurets, trimers, trimethylolpropane adduct and mixtures thereof; and / or B) a di- or tri-oxirane compound of the formula Q-(oxiran-2-ylmethyl)n CACznn / zznz / E / YiAi where n represents 2 or 3 and Q represents a C2_Ce group optionally comprising 2 to 6 nitrogen and / or oxygen atoms; v. optionally a C1-C4 compound comprising two NH2 functional groups; 3) heat the dispersion; 4) cool the dispersion. This process is described in more detail in WO 2013 / 068255, the content of which is included by reference. According to another embodiment, the microcapsule shell is made of polyurea or polyurethane. Examples of processes for preparing polyurea- and polyurethane-based microcapsule suspensions are described, for example, in WO 2007 / 004166, EP 2300146, and EP 2579976, the contents of which are also included by reference. Typically, a process for preparing polyurea- or polyurethane-based microcapsule suspensions includes the following steps: a) Dissolving at least one polyisocyanate having at least two isocyanate groups in an oil to form an oily phase; b) Prepare an aqueous solution of an emulsifier or colloidal stabilizer to form an aqueous phase; c) Add the oil phase to the aqueous phase to form an oil-in-water dispersion, where the size CRCznn / zznz / E / YiAi average droplet size is between 1 and 500 pm, preferably between 5 and 50 pm; d) Apply sufficient conditions to induce interfacial polymerization and form the microcapsules in the form of a suspension. In an alternative embodiment, the capsule can be a granule in which the hydrophobic ingredient, i.e., the polymer of the invention, is dispersed or adsorbed in a matrix or carrier that is a water-soluble material. In any given modality, the water-soluble matrix or carrier is a monomeric, oligomeric, or polymeric carrier material, or a mixture of two or more of these. An oligomeric carrier is one in which 2–10 monomeric units are linked by covalent bonds. For example, if the oligomeric carrier is a carbohydrate, it could be sucrose, lactose, raffinose, maltose, trehalose, or a fructooligosaccharide. Examples of monomeric carrier materials are glucose, fructose, mannose, galactose, arabinose, fucose, sorbitol, mannitol. Polymeric carriers have more than 10 monomeric units joined together by covalent bonds. The carrier can be a polymeric carrier material. Non-limiting examples of polymeric carrier materials include urea, acetates of CRCznn / zznz / E / YiAi polyvinyl, polyvinyl alcohol, dextrins, maltodextrins, glucose syrups, natural or modified starch, polysaccharides, carbohydrates, chitosan, gum arabic, polyethylene glycol (PEG), polyvinylpyrrolidone, acrylamides, acrylates, methacrylates, polyacrylic acid and related structures, maleic anhydride copolymers, polymers with amine functionality, polyvinylbenzyl chloride, vinyl ethers, styrenes, polystyrenesulfonates, vinyl acids, ethylene glycol propylene glycol block copolymers, vegetable ingredients, acacia gum, pectins, xanthan gum, alginates, carrageenan, cellulose or cellulose derivatives, such as carboxymethyl methylcellulose, methylcellulose, ethylcellulose, propylcellulose or hydroxyethyl Cellulose, sugar polyols / alcohols such as sorbitol, maltitol, xylitol, erythritol, and isomalt, PVP, citric acid or any water-soluble solid acid, fatty alcohols or fatty acids and mixtures thereof. According to a particular embodiment, the water-soluble polymer comprises maltodextrin having a dextrose equivalent (DE) between 3 and 20, preferably between 10 and 18. According to one embodiment, the water-soluble polymer comprises maltodextrin 18DE and / or maltodextrin 10DE. According to a particular embodiment, the water-soluble polymer comprises maltodextrin 10DE. CRCznn / zznz / E / YiAi According to one modality, the carrier is an inorganic material selected from the group consisting of sodium chloride, sodium sulfate, sodium acetate, zeolite, sodium carbonate, sodium bicarbonate, clay, talc, calcium carbonate, magnesium sulfate, gypsum, calcium sulfate, magnesium oxide, zinc oxide, titanium dioxide, calcium chloride, potassium chloride, magnesium chloride, zinc chloride. According to a particular modality, the solid carrier is sodium chloride and / or urea. According to a particular modality, the solid carrier is sodium chloride. According to a particular modality, the solid carrier is a mixture of clay and PEG, preferably the mixture comprises 0-30% clay and 20-80% PEG, preferably between 1-30% clay and 20-80% PEG, based on the total weight of the carrier. According to a particular embodiment, the solid carrier is a mixture of sodium acetate and PEG, preferably the mixture comprises 0-80% sodium acetate and 0-50% PEG, preferably 1-80% sodium acetate and 1-50% PEG. PEG preferably has a molecular weight greater than 1000 g / mol, preferably between 1000 and 8000 g / mol. Examples of microcapsules suitable for use in the present invention include, but are not limited to, CRCznn / zznz / E / viAi a, the microcapsules described in International Patent Application Publication No. WO 2007 / 026307 A2. Other examples include the microcapsules described in International Patent Application Publication No. WO 2014 / 029695 A1. Additional examples include the microcapsules described in International Patent Application Publication No. WO 2006 / 006003 A1. Additional examples include the microcapsules described in International Patent Application Publication No. WO 2006 / 018964 A1. Additional examples include the microcapsules described in International Patent Application Publication No. WO 2007 / 096790 A1. Additional examples include the microcapsules described in International Patent Application Publication No. WO 2009 / 153695 A1. Additional examples include the microcapsules described in European Patent No. EP 2379047. Examples of methods for encapsulating the compound of formula (I) include, but are not limited to, the microcapsules described in International Patent Application Publication No. WO 2007 / 026307 A2. Other examples include the microcapsules described in International Patent Application Publication No. WO 2014 / 029695 A1. Additional examples include the microcapsules described in International Patent Application Publication No. WO 2006 / 006003 A1. CRCznn / zznz / E / YiAi microcapsules described in International Patent Application Publication No. WO 2006 / 018964 A1. Additional examples include the microcapsules described in International Patent Application Publication No. WO 2007 / 096790 A1. Additional examples include the microcapsules described in International Patent Application Publication No. WO 2009 / 153695 A1. Additional examples include the microcapsules described in European Patent No. EP 2379047. The compound of formula (I) can also release flavoring ingredients. Therefore, a further aspect of the invention is a method for imparting, enhancing, improving, or modifying the flavor properties of a flavoring composition or a flavored article, comprising adding to the composition or article an effective amount of at least one compound of formula (I) as defined above. A flavoring composition or a flavored consumer product comprising at least one compound of formula (I) is also part of the invention. Examples From here on, the invention is described in more detail by means of the following examples, where abbreviations have their usual meanings in the art, and temperatures are given in degrees Celsius (°C). The NMR spectral data were recorded on a CRCznn / zznz / E / YiAi Bruker AMX 500 spectrometer at CDCI3 at 500 MHz for 3H and 125.8 MHz for 13C. Unless otherwise stated, chemical shifts δ are given in ppm with respect to Si(CH3)4 as the standard, and coupling constants J are expressed in Hz (br. = broad peak). Reactions were carried out in standard glassware under N2. Commercially available reagents and solvents were used without further purification unless otherwise stated. Although specific conformations or configurations are indicated for some of the compounds, this is not intended to limit the use of these compounds to the isomers described. According to the invention, all possible conformational or configurational isomers are expected to have a similar effect. Example 1 Preparation of compounds according to formula (I) and / or (III) that provide a long-lasting floral and fruity scent a) Synthesis of (±)-3,3'-(3,6-dioxaoctane-l,8-diylbis(sulfanediyl))bis(1-(2,6,6-trimethylcyclohex-3-en-l-yl)butan-l-one) (compound 1), (±)-3,14-dimethyl-l-(2,6,6-trimethylcyclohex-3-en-l-yl)-7,10-dioxa-4,13-dithiaicosane1,16-dione (compound 2) and (±)-2,2'-(3,6-dioxaoctane-l,8-diylbis(sulfanediyl))bis(octan-4-one) (compound 3) The (E)-trans-1-(2,6,6-trimethylcyclohex CACznn / zznz / E / YiAi 3-en-l-yl)but-2-en-l-one (trans-delta-damascone, 2.00 g, 10.4 mmol), (E)-2-octen-4-one (1.30 g, 10.4 mmol), and 1,8-dimercapto-3,6-dioxaoctane (2.00 g, 8.4 mmol) were heated at room temperature for 18 days. Column chromatography (SiO2, n-heptane / ethyl acetate 9:1 to n-heptane / ethyl acetate 4:1), concentrating, and drying under high vacuum for 1 hour yielded 0.79 g (13%) of compound 1, 0.64 g (12%) of compound 2, and 0.64 g (14%) of compound 3. The compounds were obtained as stereoisomeric mixtures. The three compounds can be used directly as a mixture, or they can be used individually after separation. RMN-1!! (compuesto 1): 5.57-5.50 (m, 2 H), 5.49-5.41 (m, 2 H), 3.70-3.59 (m, 8 H), 3.39-3.29 (m, 2 H), 2.91 (dd, J = 18.9, 4.8, 1 H), 2.81-2.66 (m, 6 H), 2.57-2.46 (m, 2 H), 2.53 (dd, J = 18.6, 8.0, 1 H), 2.21 (dd, J = 10.6, 6.7, 2 H), 2.011.91 (m, 2 H), 1.74-1.63 (m, 2 H), 1.31 y 1.30 (d, J = 6.7, 6 H), 0.99, 0.97, 0.96 y 0.95 (s, 12 H), 0.89 (2 d, J = 6.7, 6 H) . RMN-13C (compuesto 1): 212.31, 212.21, 131.82, 131.75, 124.25, 124.10, 71.00, 70.98, 70.31, 62.94, 62.83, 55.25, 55.17, 41.73, 41.72, 34.53, 34.51, 33.18, 33.06, 31.79, 31.56, 30.21, 30.14, 29.82, 29.79, 21.82, 21.63, 20.74, 20.73, 19.96, 19.88. RMN-1!! (compuesto 2): 5.57-5.50 (m, 1 H) , 5.49-5.41 (m, 1 H), 3.71-3.58 (m, 8 H), 3.39-3.26 (m, 2 H), 2.91 (dd, J CRCznn / zznz / E / YiAi = 18.6, 5.1, 0.5 Η), 2.80-2.67 (m, 6 Η), 2.57-2.47 (m, 2.5 Η), 2.46-2.34 (m, 2 Η), 2.21 (dd, J = 10.6, 6.7, 1 Η), 2.01-1.92 (m, 1 Η), 1.74-1.66 (m, 1 Η), 1.61-1.50 (m, 2 Η), 1.36-1.24 (m, 2 Η), 1.31 y 1.30 (d, J = 6.7, 3 H) , 1.28 (d, J = 6.7, 3 H) , 0.99, 0.97, 0.96 y 0.95 (s, 6 H) , 0.91 (t, J = 7.2, 3 H) , 0.89 (2 d, J = 6.7, 3 H). RMN-13C (compuesto 2): 212.32, 212.21, 208.91, 131.81, 131.75, 124.26, 124.10, 71.02, 71.00, 70.98, 70.31, 62.95, 62.83, 55.25, 55.17, 50.06, 43.35, 41.73, 41.72, 35.38, 34.54, 34.51, 33.18, 33.06, 31.79, 31.57, 30.22, 30.14, 29.82, 29.79, 25.75, 22.30, 21.82, 21.76, 21.63, 20.74, 20.73, 19.96, 19.88, 13.86. RMN-1!! (compuesto 3): 3.68-3.59 (m, 8 H) , 3.35-3.25 (m, 2 H) , 2.77-2.67 (m, 6 H) , 2.53 (dd, J = 16.7, 8.0, 2 H) , 2.47-2.34 (m, 4 H) , 1.62-1.49 (m, 4 H) , 1.37-1.25 (m, 4 H) , 1.28 (d, J = 6.7, 6 H) , 0.91 (t, J = 7.4, 6 H). 13C-NMR (compound 3): 208.92, 71.02, 70.31, 50.06, 43.34, 35.38, 30.15, 25.75, 22.30, 21.76, 13.86. Alternatively, compound 1 was prepared by slowly adding 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU, 0.79 g, 5.2 mmol) to a solution of trans-delta-damascone (21.00 g, 109.4 mmol) and 1,8-dimercapto-3,6-dioxaoctane (10.00 g, 52.1 mmol) in tetrahydrofuran (THF, 100 mL). After stirring at room temperature for 18 hours, n-heptane (100 mL) was added, and the mixture was treated with an aqueous solution CRCznn / zznz / E / YiA of HC1 (10%, 100 ml) was washed with a saturated aqueous solution of NaCl (2 x 100 ml). The organic layer was dried (Na2SO4), filtered, and concentrated. Bulb-to-bulb distillation (120 °C, 0.08 mbar, 2 hours) to remove the remaining volatiles yielded 27.87 g (99%) of compound 1. Alternatively, compound 3 was prepared by shaking (E)-2-octen-4-one (31.6 g, 250.4 mmol) and 1,8-dimercapto-3,6-dioxaoctane (2,2'-(ethylenedioxy)diethanethiol, 21.8 g, 113.7 mmol) at room temperature for 28 days. Bulb-to-bulb distillation (100 °C, 0.04 mbar) to remove remaining volatiles yielded 51.28 g (quantity) of compound 3. (b) Synthesis of (±)-2,2'-(3,6-dioxaoctane-1,8-diylbis(sulfanediyl))bis(octan-4-one) (compound 3) and (±)-2((2-(2-(2-mercaptoethoxy)ethoxy)ethyl)thio)octan-4-one (compound 4) (E)-2-octen-4-one (3.75 g, 29.7 mmol) and 1,8-dimercapto-3,6-dioxaoctane (3.61 g, 19.8 mmol) were stirred at room temperature for 9 days. Column chromatography (SiO2, n-heptane / ethyl acetate 4:1 and n-heptane / ethyl acetate 3:2) yielded 1.37 g of a mixture of compound 3 and compound 4 in a 35:65 ratio. The compounds can be used directly as a mixture. Additional reversed-phase column chromatography (RP Vydac 218TP C18, water / acetonitrile 7:3 and water / acetonitrile 6:4) yielded 0.89 g of compound 4. CRCznn / zznz / E / viAi NMR-1!! (compound 4): 3.67-3.59 (m, 8 H), 3.36-3.26 (m, 1 H), 2.77-2.67 (m, 5 H), 2.57-2.49 (m, 1 H), 2.46-2.35 (m, 2 H), 1.63-1.51 (m, 3 H), 1.36-1.25 (m, 2 H), 1.28 (d, J = 6.7, 3 H), 0.91 (t, J = 7.3, 3 H). 13C-NMR (compound 4): 208.91, 72.93, 71.04, 70.29, 70.21, 50.06, 43.35, 35.38, 30.20, 25.74, 24.27, 22.30, 21.76, 13.86. (c) Synthesis of (±)-3,3'-(3,6-dioxaoctane-l,8-diyldisulfonyl)bis(1-(2,6,6-trimethylcyclohex-3-en-l-yl)butanl-one) (compound 5) A solution of Oxone (2 KHSO5 / KHSO4 / K2SO4, 64.1 g, 421.4 mmol, 9.8 eq.) in water (220 ml) was added dropwise to a stirred solution of (±)-3,3'-(3,6-dioxaoctane-1,8-diylbis(sulfanediyl))bis(1-(2,6,6-trimethylcyclohex-3-en-1-yl)butan-1-one) (compound 1, 24.4 g, 43.0 mmol) in methanol (330 ml), which was cooled to 1 °C in an ice bath. After introduction, the ice bath was removed, and the suspension was stirred for 18 hours. The reaction mixture was extracted with ethyl acetate (350 ml), washed with a saturated aqueous solution of NaCl (200 ml), deionized water (200 ml), a saturated aqueous solution of NaHCOs (200 ml) and a saturated aqueous solution of NaCl (200 ml). Each of the aqueous phases was re-extracted with ethyl acetate (250 ml). The combined organic phases were dried (Na2SO4), filtered, and concentrated. Drying at high CRCznn / zznz / E / viAi under vacuum (0.51 mbar) at 50 °C for 5 hours yielded 25.05 g (81%) of compound 5 as a mixture of two pairs of diastereomers (approx. 1.5:1), which can be used as such. Column chromatography of 1.0 g (SiO2, n-heptane / ethyl acetate 9:1, then 8:2, then 7:1, then 1:1) yielded 0.49 g (45%) of an analytically pure sample. NMR-1!! (main isomers): 5.59-5.51 (m, 2 H), 5.48-5.42 (m, 2 H), 4.01-3.87 (m, 4 H), 3.87-3.76 (m, 2 H), 3.69-3.62 (m, 4 H), 3.48-3.37 (m, 2 H), 3.22-3.05 (m, 4 H), 2.85 (ddd, J = 18.9, 10.3, 1.2 Hz, 2H), 2.57-2.45 (m, 2H), 2.29 (d, J = 10.6 Hz, 2 H), 2.03-1.93 (m, 2 H), 1.76-1.67(m, H), 1.39 (t, J = 6.4 Hz, 6 H), 0.98 (s, 6 H), 0.95 (s, 6 H), 0.90 (d, J = 6.7 Hz, 6H). NMR-13C (major isomers): 210.53 and 210.50, 131.47 and 131.46, 124.21 and 124.20, 70.50, 64.69, 63.01 and 62.99, 53.95, 50.74 and 50.72, 45.65 and 45.47, respectively, 29.78, 8.74pm, 7.90pm, 2.11pm. ΗΜΝ-3Η (secondary isomers): 5.59–5.51 (m, 2 H) , 5.48–5.42 (m, 2 H) , 4.01–3.87 (m, 4 H) , 3.87–3.76 (m, 2H) , 3.69– 3.62 (m, 4 H) , 3.48–3.37 (m, 2 H) , 3.35–3.28 (m, 2H) , 3.22- 3.10 (m, 2 H), 2.62 (dd, J = 18.9, 9.9 Hz, 2 H), 2.29(d, J = 10.6 Hz, 2 H) , 2.03–1.93 (m, 2 H), 1.76–1.67 (m, 2 H) , 1.39 (t, J = 6.4 Hz, 6 H) , 0.99 (s, 6 H) , 0.90 (s, 0.9 H6), 0.90 (s Hz, 6 H), 1.01–0.92 (m, 2 H). CRCznn / zznz / E / YiAi NMR-13C (secondary isomers): 210.73 and 210.69, 131.42, 124.42, 70.53, 64.66, 63.33 and 63.31, 53.98, 50.75 and 45.69, respectively. 41.57, 33.04, 32.08, 29.73, 20.77, 19.90, 13.92 and 13.91. (d) Synthesis of (±) -2,2'-(3,6-dioxaoctano-l,8- diyldisulfonyl)bis(octan-4-one) (compound 6) A solution of Oxone (2 KHSO5 / KHSO4 / K2SO4, 103.0 g, 676.5 mmol, 9.8 eq.) in water (400 mL) was added dropwise to a mechanically stirred solution of (±)-2,2'-(3,6-dioxaoctane-1,8-dibis(sulfanediyl))bis(octan-4-one) (compound 3, 30.0 g, 69.0 mmol) in methanol (500 mL), which was cooled to 1 °C in an ice bath. After the introduction, the ice bath was removed, and stirring of the suspension continued for 18 hours. The reaction mixture was filtered through sintered glass and rinsed with water (100 mL). The residue was collected in ethyl acetate (300 mL), washed with demineralized water (200 mL), a saturated aqueous solution of NaHCO3 (200 mL), and a saturated aqueous solution of NaCl (200 mL). Each of the aqueous phases was re-extracted with ethyl acetate (200 mL). The combined organic phases were dried (Na2SO4), filtered, and concentrated. Drying under high vacuum (0.61 mbar) for 2 hours yielded 16.3 g of a pair of diastereomers in a 3:1 ratio. The mother liquors obtained from filtration through sintered glass were concentrated. CRCznn / zznz / E / YiAi was used to remove as much methanol as possible. The remaining aqueous phase was extracted with ethyl acetate (2x, 200 mL). The organic phase was washed with demineralized water (200 mL), a saturated aqueous solution of NaHCO3 (200 mL), and a saturated aqueous solution of NaCl (200 mL), then dried (Na2SO4), filtered, and concentrated. Drying under high vacuum (0.61 mbar) for 2 hours yielded 17.4 g of a slightly yellow oil as the same pair of diastereomers in a 1:3 ratio, which crystallized slowly. The two product fractions were recombined to provide compound 6 as a mixture of diastereomers in an approximately 1:1 ratio. 1H-NMR (600 MHz): 3.99-3.86 (m, 4 H), 3.86-3.77 (m, 2 H), 3.68-3.62 (m, 4 H), 3.42-3.33 (m, 2 H), 3.20-3.12 (m, 4 H), 2.61 (dd, J = 18.1, 9.2, 2 H), 2.53-2.39 (m, 4 H), 1.621.52 (m, 4 H), 1.36-1.27 (m, 4 H), 1.36 and 1.35 (d, J = 6.6, 6 H), 0.91 (t, J = 7.3, 6 H). 13C-RMN (151.0 MHz): 206.87 and 206.85, 70.52 and 70.50, 64.67, 54.24 and 54.22, 50.89 and 50.86, 43.18, 40.77 and 40.70, 25.81, 22.25, 14.02 and 13.98, 13.81. (e) Synthesis of (±)-2,2'-(hexane-1,6-diylbis(sulfanediyl))bis(octan-4-one) (compound 7) (E)-2-octen-4-one (9.2 g, 73.2 mmol) and 1,6-hexanedithiol (5.0 g, 33.3 mmol) were stirred at temperature CRCznn / zznz / E / YiAi was left at room temperature for 48 days. Heating the reaction mixture to 50 °C under high vacuum (0.61 mbar) for 1 hour to remove remaining volatiles yielded 12.6 g of the unrefined compound as a light yellow oil. Column chromatography of 2.0 g (SiO2, n-heptane / ethyl acetate 9:1) provided 1.38 g (65%) of compound 7. iH-NMR: 3.30-3.20 (m, 2 H), 2.70 (dd, J = 16.7, 5.8, 2 H), 2.57-2.48 (m, 6 H), 2.47-2.35 (m, 4 H), 1.63-1.50 (m, 8 H), 1.45-1.24 (m, 8 H), 1.27 (d, J = 6.7, 6 H), 0.91 (t, J = 7.4, 6 H). 13C-NMR: 209.13, 50.11, 43.49, 35.10, 30.75, 29.56, 28.54, 25.75, 22.31, 21.73, 13.86. (f) Synthesis of (±)-2,2'-(hexane-1,6-diyldisulfonyl)bis(octan4-one) (compound 8) An Oxone solution was added dropwise (2 KHSO5 / KHSO4 / K2SO4, 18.5 g, 121.7 mmol, 9.8 eq.) in water (45 ml) to a stirred solution of (±)-2,2'-(hexane-1,6diylbis(sulfanediyl))bis(octan-4-one) (compound 7, 5.0 g, 12.4 mmol) in methanol (75 mL), which was cooled to °C in an ice bath. After introduction, the ice bath was removed, and the suspension was stirred for 18 hours. The reaction mixture was extracted with ethyl acetate (200 mL), washed with a saturated aqueous solution of NaCl (100 mL), deionized water (100 mL), a saturated aqueous solution of NaHCO3 (100 mL), and a saturated aqueous solution of NaCl (100 mL). Each of the aqueous phases was re-extracted with CRCznn / zznz / E / YiAi ethyl acetate (150 ml). The combined organic phases were dried (Na2SO4), filtered and concentrated. Drying under high vacuum (0.61 mbar) for 2 hours yielded 4.73 g (81%) of compound 8. ΗΜΝ-^: 3.66-3.57 (m, 2 H) , 3.18 (dd, J = 18.0, 4.2, 2 H) , 2.94 (t, J = 7.9, 4 H) , 2.60 (dd, J = 18.0, 8.7, 2 H, 2.5 H) . 4 H) , 1.96-1.79 (m, 4 H) , 1.65-1.46 (m, 8 H) , 1.37 (d, J = 7.1, 6 H) , 1.37-1.2 8 (m, 4 H), 0.91 (t, J = 7.4, 6 H) . NMR-13C: 206.81, 52.66, 50.03, 43.07, 41.09, 28.07, 25.79, 25.25, 21.24, 14.47, 13.80. (g) Synthesis of 4,4'-(3,6-dioxaoctano-l,8- diylbis(sulfanodiyl))bis(4-methylpentan-2-one) (compound 9) DBU (0.87 g, 5.7 mmol) was slowly added to a solution of 4-methyl-3-penten-2-one (12.30 g, 125.5 mmol) and 1,8-dimercapto-3,6-dioxaoctane (10.40 g, 57.1 mmol) in 50 mL of THE. After stirring at room temperature for 3 days, n-heptane (50 mL) was added. The mixture was treated with 10% aqueous HCl (50 mL) and washed with saturated aqueous NaCl (2 x 50 mL). The organic layer was dried (Na₂SO₄), filtered, and concentrated. Bulb-to-bulb distillation (90 °C, 0.05 mbar, 2 hours) to remove remaining volatiles yielded 17.90 g (83%) of compound 9. 3H-NMR: 3.66-3.58 (m, 8 H), 2.77 (t, J = 7.1, 4 H), 2.70 (s, 4 H), 2.19 (s, 6 H), 1.42 (s, 12 H). 13C-NMR: 206.70, 70.86, 70.33, 54.61, 43.59, 32.33, CACznn / zznz / E / YiAi 28.49, 27.85. (h) Synthesis of 4-((6-mercaptohexyl)thio)-4-methylpentan-2-one (compound 10) and 4,4'-(hexane-1,6-diylbis(sulfanediyl))bis(4-methylpentan-2-one) (compound 11) DBU (0.52 g, 3.4 mmol) was slowly added to a solution of 4-methyl-3-penten-2-one (5.00 g, 51.0 mmol) and 1,6-hexanedithiol (10.00 g, 52.1 mmol) in THF (50 ml). After stirring at room temperature for 18 hours, n-heptane (50 ml) was added, and the mixture was treated with an aqueous solution of HCl (10%, 50 ml) and washed with a saturated aqueous solution of NaCl (2 x 50 ml). The organic layer was dried (Na2SO4), filtered, and concentrated. The compounds can be used directly as a mixture. Column chromatography (SiO2, nheptane / ethyl acetate 9:1) yielded 2.61 g (31%) of compound 10 and 6.43 g (55%) of compound 11. ΒΜΝ-3Η (compound 10): 2.69 (s, 2 H), 2.57-2.49 (m, 4 H), 2.19 (s, 3 H), 1.68-1.52 (m, 4 H), 1.46-1.36 (m, 4 H), 1.42 (s, 6 H), 1.33 (t, J = 7.7, 1H). 13C-NMR (compound 10): 206.92, 54.70, 43.35, 33.80, 32.36, 29.35, 28.62, 28.52, 28.00, 27.94, 24.53. ΒΜΝ-3Η (compuesto 11): 2.69 (s, 4 H) , 2.54 (t, J = 7.3), 4 H), 2.19 (s, 6 H), 1.62-1.52 (m, 4 H), 1.46-1.36 (m, 4 H) , 1.42 (s, 12 H) . RMN-13C (compuesto 11): 206.92, 54.70, 43.35, 32.36, 29.36, 28.84, 28.52, 28.02. CRCznn / zznz / E / YiA (i) Síntesis de 3-((6-mercaptohexil)tio)-1-(2,6,6trimetilciclohexa-1,3-dien-l-yl)butan-l-ona (compuesto 12), 3,3'-(hexano-1,6-diiIbis(sulfanodiil))bis(l-(2,6,6trimetilciclohexa-1,3-dien-l-yl)butan-l-ona) (compuesto 13), 4-meti1-4-((6-((4-oxo-4-(2,6,6-trimetilciclohexa-l,3-dien-lil)butan-2-il)tio)hexil)tio)pentan-2-ona (compuesto 14) y 4((6-mercaptohexyl)thio)-4-methylpentan-2-ona (compound 10) (E)-1-(2,6,6-trimethylcyclohexa-l,3-dien-lyl)but-2-en-l-one (3.81 g, 20.0 mmol), 4-methyl-3-penten-2-one (1.96 g, 20.0 mmol) and 1,6-hexanedithiol (3.01 g, 20.0 mmol) were stirred at room temperature for 30 days. Column chromatography (S1O2, n-heptane to n-heptane / ethyl acetate 95:5) provided 0.44 g of a mixture of 1,6hexanedithiol and compound 12 (approx. 55:45), 0.85 g of a mixture of compound 12 and compound 13 (approx. 34:66) and 0.03 g of compound 13. Further elution (n-heptane / ethyl acetate 9:1 to 1:1) provided 0.13 g of a mixture of compound 14 and compound 10 (approx. 50:50). dy-NMR (compound 12): 5.87-5.75 (m, 2 H), 3.40-3.31 (m, 1 H), 2.89 (dd, J = 18.3, 4.8, 1 H), 2.72 (dd, J = 18.6, 8.3, 1 H), 2.59-2.49 (m, 4 H), 2.11-2.06 (m, 2 H), 1.73 (s, 3 H), 1.66-1.56 (4 H), 1.45-1.37 (4 H), 1.34 (d, J = 7.1, 3 H), 1.08 (s, 6 H). 13C-NMR (compound 12): 207.63, 141.55, 128.11, 127.72, 127.52, 52.94, 39.74, 34.27, 33.85, 33.85, 30.84, CRCznn / zznz / E / YiAi 29.54, 28.39, 27.93, 26.20 (2x) , 24.54, 21.76, 19.10. RMN-1!! (compuesto 13): 5.87-5.75 (m, 4 H) , 3.41-3.31 (m, 2 H) , 2.89 (dd, J = 18.3, 4.8, 2 H), 2.72 (dd, J = 18.3, 8.3, 2 H), 2.55 (t, J = 7.4, 4 H) , 2.11-2.06 (m, 4 H), 1.73 (s, 6 H) , 1.65-1.54 (m, 4H), 1.45-1.37 (m, 4 H), 1.34 (d, J=6.7, 6 H), 1.08 (s, 12 H). RMN-13C (compuesto 13): 207.63, 141.56, 128.11, 127.70, 127.50, 52.93, 39.74, 34.28, 33.85, 30.84, 29.58, 28.61, 26.21, 26.19, 21.74, 19.09. RMN-3H (compuesto 14): 5.87-5.81 (m, 1 H) , 5.81-5.75 (m, 1 H), 3.41-3.31 (m, 1 H), 2.89 (dd, J= 18.6, 4.8, 1 H), 2.72 (dd, J = 18.6, 8.3, 1 H), 2.69 (s, 2 H), 2.59-2.49 (m, 4 H), 2.19 (s, 3 H), 2.11-2.07 (m, 2 H), 1.73 (s, 3 H), 1.66-1.53 (m, 4 H), 1.45-1.38 (m, 4 H) , 1.42 (s, 6 H), 1.34 (d, J = 6.7, 3 H), 1.08 (s, 6 H) . 13C-NMR (compound 14): 207.63, 206.97, 141.55, 128.11, 127.72, 127.52, 54.71, 52.93, 43.35, 39.74, 34.27, 33.86, 32.37, 30.86, 29.55, 29.39, 28.84, 28.61, 28.51, 28.03, 26.20, 21.76, 19.10. (j) Synthesis of (3R,3'R)-6,6'-((decane-1,10-diylbis(sulfanediyl))bis(propane-2,2-diyl))bis(3-methylcyclohexan-1-one) (compound 15) DBU (0.26 g, 1.7 mmol) was slowly added to a solution of (R)-5-methyl-2-(propan-2-ylidene)cyclohexan-1-one (5.60 g, 36.8 mmol) and 1,10-decanedithiol (3.45 g, 16.7 mmol) in THF (50 mL). After stirring at room temperature for 18 hours, n-heptane (50 mL) was added, and the mixture was treated with an aqueous solution of HCl (10%, 50 mL) and washed with a CRCznn / zznz / E / YiAi saturated aqueous NaCl solution (2 x 50 mL). The organic layer was dried (NagSCU), filtered, and concentrated to give 8.93 g of the unrefined compound. Column chromatography on 3.0 g (SiO2, n-heptane / ethyl acetate 95:5) provided 0.31 g (10%) of compound 15 as a mixture of isomers (approx. 2:1). NMR-1!! (main isomer): 2.61-2.39 (m, 8 H), 2.382.24 (m, 2 H), 2.08-2.00 (m, 2 H), 1.99-1.82 (m, 4 H), 1.591.49 (m, 6 H), 1.51 (s, 6 H), 1.42-1.33 (m, 6 H), 1.36 (s, 6 H), 1.33-1.22 (m, 8 H), 1.02 (d, J = 6.4, 6 H). 13C-NMR (main isomer): 210.82, 58.06, 52.43, 48.85, 36.71, 34.75, 29.66, 29.53, 29.43, 29.27 (2x) , 27.93, 27.69, 23.96, 22.28. NMR-1!! (secondary isomer): 2.61-2.39 (m, 8 H), 2.382.24 (m, 4 H), 2.14-2.08 (m, 2 H), 1.99-1.82 (m, 4 H), 1.71-1.61 (m, 2 H), 1.59-1.49 (m, 4 H), 1.48 (s, 6 H), 1.42-1.33 (m, 4 H), 1.37 (s, 6 H), 1.33-1.22 (m, 8 H), 0.96 (d, J = 7.1, 6 H). 13C-NMR (secondary isomer): 211.60, 58.24, 50.44, 47.00, 32.69, 31.45, 29.51, 29.43, 29.27 (2x), 28.32, 27.81, 25.53, 24.71, 19.29. Example 2 Performance of a model surface cleaner comprising a compound of formula (I) of the invention - Comparison of fragrance release from monomeric and dimeric structures Compound 11 (76.8 mg) was dissolved in 2-propanol (0.2 mL). Then, an aqueous solution of lauryl ether was added. CRCznn / zznz / E / YiAi sodium sulfate (10% SLES) was added to make up 5 g, representing a simplified model surface cleaner formulation. An aliquot of this solution (90 mg) was spread onto a glass plate (2.5 x 7.5 cm) and allowed to dry for 24 hours. The glass plate was then placed in a homemade overhead space cell (approximately 625 ml internal volume), and a continuous flow of air (approximately 200 ml / min) was drawn through the sampling cell. The airflow was passed through activated carbon and a saturated aqueous NaCl solution to ensure a constant humidity of 75%. The volatiles were then alternately adsorbed onto a discarded Tenax® cartridge for 15 minutes and a clean Tenax® cartridge for another 15 minutes, for a total of 3 hours (180 minutes) to collect 6 data points.The waste cartridges were discarded; the remaining cartridges were desorbed in a Markes TD 100-XR desorber (at 280 °C for 10 minutes), and the volatiles were injected into an Agilent Technologies 7890A gas chromatograph equipped with a Supelco SPB1 capillary column (30 m, 0.25 mm diameter, 0.25 pm film) and coupled to an Agilent 5975C inert MSD mass spectrometer. The volatiles were eluted with a flow of He at 0.9 mL / min using a temperature gradient ranging from 40 °C (for 1 minute) to 180 °C at 10 °C / min and to 260 °C at 30 °C / min. Concentrations in the headspace (in ng / L of air) were obtained using standard calibrations. CRCznn / zznz / E / YiAi external using different concentrations of 4-methylpent3-en-2-one as the fragrance to be released in ethanol. Each calibration solution (0.2 μA) was injected into a clean Tenax® cartridge, which was desorbed and analyzed under the same conditions. The same experiment was carried out using 4(dodecylthio)-4-methylpentan-2-one as the reference compound. The synthesis of this compound has been described in the prior art (JR Stephens, JJ Hydock, M. P. Kleinholz, J. Am. Chem. Soc., 1951, 73, 4050). The average concentrations in the upper space (average values of the 6 data points) obtained from two measurements are listed in Table 1. Table 1: Average concentrations in the upper space of fragrances released from the compounds of formula (I) with respect to a prior art reference compound on a glass plate after drying for 1 day. CRCznn / zznz / E / YiAi Compound Concentration of 4-methylpent-3-en-2-one released [ng / 1] Increase in release from the compound of the invention with respect to the reference compound Prior art reference compound 1.6 approx. 33% Compound 11 according to the present invention 2.1 Dimeric compounds according to formula (I) (with Q being a divalent hydrocarbon group) are therefore more efficient in releasing fragrance raw materials than the corresponding monomeric analogues of the prior art (with Q being a monovalent hydrocarbon group). Example 3 Performance of a fabric softener base comprising a compound of formula (I) of the invention The generation of long-lasting fresh green, floral, and fruity scents from the compounds of formula (I) of the present invention was tested in a fabric softening surfactant emulsion with the following final composition: Stepantex® VL90 A (origin: Stepan) 12.21% by weight Calcium chloride (10% acid solution) 0.40% by weight Proxel® GXL (origin: Avecia) 0.04% by weight Water 87.35% by weight CACznn / zznz / E / YiAi In a flask, a solution (0.1 ml) of one of the compounds of formula (I) of the invention described in Example 1 (in an amount to release a total of 0.05 mmol of a given fragrance) in ethanol (10 ml) was added to fabric softener (0.07 g) and diluted with cold demineralized tap water (23 g). The sample was vigorously shaken (10 times). Then, a cotton sheet (EMPA cotton test cloth number 221, origin: Eidgenóssische Materialprüfanstalt), pre-washed with an unscented detergent powder and cut to approximately 15 x 15 cm sheets (approximately 5.1 g), was added and shaken manually for 3 minutes, allowed to stand for 2 minutes, then manually squeezed, and weighed (approximately 10.0 g) to obtain a constant amount of residual water. A reference sample (0.1 ml) consisting of an equimolar amount of the unmodified fragrance (0.05 mmol) in ethanol (10 ml) was added to the fabric softener (0.07 g) in water (23 g) and analyzed in the same way.The cotton sheets were line-dried for 1 or 3 days before analysis. For measurements, the sheets were placed in an overhead sampling cell (approximately 165 ml internal volume), which was thermostatically controlled at 25 °C and exposed to a constant airflow of approximately 200 ml / min. The air was filtered through activated carbon and drawn through a saturated NaCl solution (to ensure a constant air humidity of approximately 75%). The system was equilibrated for 15 minutes while the volatiles were adsorbed onto a waste Tenax® cartridge (filled with 100 mg of Tenax® TA adsorbent resin). Then, seven consecutive times, the volatiles were adsorbed for 15 minutes onto a clean Tenax® cartridge and for 45 minutes onto a Tenax® cartridge. CRCznn / zznz / E / viAi waste. Waste cartridges were disposed of; the other cartridges were desorbed in a Perkin Elmer TurboMatrix 350 desorber coupled to an Agilent Technologies 7890A gas chromatograph equipped with an HP-1 capillary column (30 m, di 0.25 mm, film 0.25 pm) and an Agilent 5975C inert MSD spectrometer. Volatiles were eluted with helium (1 ml / min) using a temperature gradient ranging from 60 °C (held for 1 minute) to 200 °C at 10 °C / min. Alternatively, the cartridges were desorbed in a Perkin Elmer TurboMatrix desorber coupled to an Agilent Technologies 7890A gas chromatograph with an HP-1 capillary column (30 m, 0.32 mm diameter, 0.25 pm film thickness) and a flame ionization detector. Volatiles were eluted with helium (1 mL / min) using a temperature gradient ranging from 80 °C to 220 °C at 10 °C / min.Concentrations in the headspace (in ng / L of air) were obtained using external standard calibrations. Solutions of the fragrances to be released at different concentrations in ethanol were injected (0.2 pl) into a clean Tenax® cartridge, which was then desorbed and analyzed under the same conditions. The results obtained for fragrance evaporation after a total sampling time of 150 minutes on dry cotton following line drying for 1 and 3 days are summarized in Table 2. All data are average values. CACznn / zznz / E / YiAi from at least two measurements. Table 2: Average concentrations in the upper space of fragrances released from the compounds of formula (I) measured after sampling© for 150 minutes over CRCznn / zznz / E / YiAi dry cotton after line drying for 1 and 3 days. Compound Concentration of (E)-2-octen-4one (strawberry fruity odor) [ng / 1] measured after line drying for 1 day Concentration of (E)-trans-l(2,6,6-trimethylcyclohex-3-en-l-yl)but2-en-l-one (rose fruity odor) [ng / 1] measured after line drying for 1 day Reference approx. 1.3 approx. 0.1 Compound 1 ___ 15.8 Compound 2 18.3 11.9 Compound 3 18.1 ___ Compound 3 and compound 4 (9:1) 20.6 ___ Compound 5 ___ 3.2 Compound 6 7.8 ___ Compound 7 20.0 ___ Compound 8 5.3 ___ Concentration of (E)-2-octen-4one (strawberry fruity odor) [ng / 1] measured after line drying for 3 days Concentration of (E)-trans-l(2,6,6-trimethylcyclohex-3-en-l-yl)but2-en-l-one (rose fruity odor) [ng / 1] measured after line drying for 3 days Reference approx. 0.7 approx. 0.1 Compound 1 ___ 12.8 Compound 2 19.3 19.4 Compound 3 16.5 ___ Compound 3 and Compound 4 (9:1) 16.0 ___ Compound 5 ___ 1.5 Compound 6 12.3 ___ Compound 7 15.3 ___ Compound 8 5.7 ___ Concentration of 4-methylpent-3en-2-one (green odor, similar to sweet honey) [ng / L] measured after line drying for 1 day. Concentration of 5-methyl-2(propan-2-ylidene)cyclohexan-1-one (herbaceous-menthol odor) [ng / L] measured after line drying for 1 day. Reference approx. 0.6 approx. 0.8 Compound 9 3.0 ___ Compound 11 13.1 ___ Compound 15 ___ 4.8 CRCznn / zznz / E / YiAi The compounds according to formula (I) released greater quantities of fresh green, floral, and fruity scents in the upper space on dry cotton than the reference sample with the unmodified fragrances. The compounds of formula (I) according to the present invention are therefore capable of imparting long-lasting fresh green, floral, and fruity scents to a cotton surface. Example 4 Preparation of a perfume oil A non-limiting example of a typical perfume vinegar is prepared by mixing the following perfuming co-ingredients: Ingredients 2-Methylbutanoate of ethyl Acetato de hexilo Limoneno 2,6-Dimethyl-7-octen-2-ol % by weight 0.16 0.37 1.67 0.94 2-Phenylethanol Linalool0.73 (2RS,4SR / 4RS)-4-Methyl-2-(2-methyl-l-propene-lyl)tetrahydro-2H-pyran0.30 2-Methyl-1,3-dioxolano-2-acetato de ethyl0.32 Acetato de bencilo2.46 Alilo heptanoate0.38 alpha-Terpineol0.88 3,7-Dimethyl-6-octen-l-ol0.55 4-Methoxybenzaldehido1.00 (E)-4-Methyl-3-decen-5-ol0.37 [cis / trans-4-(2-Propanyl)cyclohexyl]methanol0.47 l-Methoxy-4-[(1E)-1-propen-l-yl]benceno0.15 Acetate de (1RS,2RS / 2SR)-2-(2-methyl-2propanyl)cyclohexylo1.95 1,l-dimethyl-2-phenylethyl acetate0.95 Tricycle acetate [5.2.1. O2'~] dec-3 / 4-en-8-ilo3.34 3-Cyclohexylpropanoate de alilo0.26 3-(4-Isopropylphenyl)-2-methylpropanal8.18 (3E)-3-Methy1-4-(2,6,6-trimethyl-2-cyclohexen-l-yl)-3buten-2-ona y (1E)-1-(2,6,6-trimethyl-2-cyclohexen-lyl)-l-penten-3-ona1.13 2-Methylpropanoate de 2-phenoxyethyl5.38 Tricyclopropanoate[5.2.1.0(2,6)]dec-3 / 4-en-8-ilo2.32 5-Heptyldihydro-2(3H)-furanona2.30 2 / 3-methylbutyl salicylate1.42 Salicylate de (3Z)-3-hexen-l-ilo0.31 1-(2,3,8,8-Tetramethyl-1,3,4,5,6,7-hexahidronaphthalene-2yl)etanona16.03 2-Hidroxybenzoato de hexilo5.04 (2E)-2-Bencilidenoctanal 21.22 CRCznn / zznz / E / viA (-) -(3aR,5aS,9aS,9bR)-3a,6,6,9aTetramethyldodecahydronaphtho[ 2,1-b]furan0.27 Habanolide®4.78 Exaltolide®3.82 2-Hidroxibenzoato de bencilo3.01 Dipropylene glycol5.39 Total: 100 Example 5 Preparation of liquid detergent formulations comprising a compound of formula (I) of the invention Table 3 lists a typical unscented liquid detergent formulation. A scented liquid detergent was prepared by adding, under gentle stirring, a perfume oil (0.3 to 0.8% by weight relative to the total weight of the liquid detergent) and at least one of the compounds of formula (I) of the invention (0.05 to 1.0% by weight relative to the total weight of the liquid detergent) to the unscented liquid detergent formulation of Table 3. Table 3: Composition of a typical unscented liquid detergent formulation Ingredients Quantity [% by weight] Sodium C14-17 alkyl sulfonate sec. 7.0 C12-18 and cis<2 unsaturated fatty acids 7.5 C12 / 14 fatty alcohol polyglycol ether with 7 mol EO(3) 17.0 Triethanolamine 7.5 Propylene glycol 11.0 Citric acid 6.5 Potassium hydroxide 9.5 Properase® L(4) 0.2 Puradax® EG L (4) 0.2 Purastar® ST L (4) 0.2 Acrylates / Steareth-20 methacrylate structuring crosspolymer 6.0 Deionized water 27.4 CRCznn / zznz / E / viAi(1)Hostapur® SAS 60; origin: Clariant(2)Edenor® K 12-18; origin: Cognis(3) Genapol® LA 070; origin: Clariant(4) Origin: Genencor International(5)Aculyn® 88; origin: Dow Chemicals Example 6 Preparation of multipurpose cleaning formulations comprising a compound of formula (I) of the invention Table 4 lists a typical multipurpose cleaning formulation. A scented multipurpose cleaner was prepared by adding, under gentle stirring, a perfume oil (0.3 to 0.8% by weight of the total weight of the multipurpose cleaner) and at least one of the compounds of formula (I) of the invention (0.05 to 0.8% by weight of the total weight of the multipurpose cleaner) to the unscented multipurpose cleaning formulation of Table 4. Table 4: Composition of a typical unscented multipurpose cleaning formulation Ingredients Quantity [% by weight] Ethoxylated alcohol (C9-C11, 8 EO)(1) 20.0 Sodium dodecylbenzene sulfonate (2) 16.0 Sodium eumene sulfonate (3) 8.0 Methylchloroisothiazolinone / methylisothiazolinone 3.3:1 (4) 0.8 Deionized water 55.9 CRCznn / zznz / E / YiAi(1)Neodol® 91-8; origin: Shell Chemicals(2)Biosoft® D-40; origin: Stepan (T Stepanate® SCS; origin: Stepan(4)Kathon® CG; origin: Dow Chemicals Example 7 Preparation of transparent isotropic shampoo formulations comprising a compound of formula (I) of the invention Table 5 lists a typical unscented, clear, isotropic shampoo formulation. The unscented shampoo formulation was prepared by dispersing polyquaternium-10 in water. The remaining Phase A ingredients were mixed separately by adding them one after the other, mixing thoroughly after each addition. This premix was added to the polyquaternium-10 dispersion and mixed for another 5 minutes. Then, the premixed Phase B and premixed Phase C (Monomuls® 90L-12 heated to melt in Texapon® NSO IS) were added under stirring. Phase D and Phase E were added under stirring. The pH was adjusted with citric acid solution to 5.5–6.0 to obtain the unscented shampoo formulation listed in Table 5. Table 5: Composition of a typical unscented, transparent, isotropic shampoo formulation CRCznn / zznz / E / YiAi Phase Ingredients Quantity [% by weight] A Deionized water 44.4 Polyquaternium-10(1) 0.3 85% Glycerin (2) 1.0 DMDM Hydantoin (3) 0.2 B Sodium laureth sulfate (4) 28.0 Cocamidopropyl betaine(5) 3.2 Disodium cocoamphodiacetate (6) 4.0 Stearyl ethoxy(20) alcohol (7) 1.0 C Sodium laureth sulfate (4) 3.0 Glyceryl laureate(8) 0.2 D Deionized water 1.0 Sodium methylparaben (9) 0.1 E Sodium chloride (10% aqueous solution) 15.0 Citric acid (10% aqueous solution at pH 5.5-6.0) q.s. Ucare® JR-400 Polymer; origin: Noveon Origin: Brenntag Schweizerhall AG(3)Glydant®; origin: Lonza(4)Texapon® NSO IS; origin: Cognis(5)Betaine F 50 from Tego®; origin: Evonik <6> Amphotensid GB 2009; origin: Zschimmer & Schwarz (7) Brij® S20; origin: Croda(8> Monomuls® 90 L-12; origin: Gruenau GmbH(9> Nipagin Monosodium; origin: ÑIPA The perfumed shampoo formulation was obtained by adding, under gentle stirring, a perfume oil (0.1 to 0.8% by weight relative to the total weight of the unperfumed shampoo formulation) and at least one of the compounds of formula (I) (0.05 to 0.5% by weight relative to the total weight of the unperfumed shampoo formulation) to the unperfumed shampoo formulation listed in Table 5. Example 8 Preparation of pearlescent shampoo formulations comprising a compound of formula (I) of the invention Table 6 lists a typical unscented pearlescent shampoo formulation. The unscented shampoo formulation was prepared by dispersing tetrasodium EDTA, guar hydroxypropyltrimonium chloride, and polyquaternium-10 in water. NaOH (10% aqueous solution, phase B) was added once phase A was homogeneous. The premixed phase C was then added, and the mixture was heated to 75 °C. The ingredients of phase D were added and mixed until homogeneous. The mixture was cooled. At 45 °C, the ingredients of phase E were added while mixing. The final viscosity was adjusted with NaCl (25% aqueous solution), and the pH was adjusted to 5.5–6.0 with NaOH (10% aqueous solution). CRCznn / zznz / E / YiAi Table 6: Composition of a typical pearlescent shampoo formulation Phase Ingredients Quantity [% by weight] A Deionized water 45.97 Tetrasodium EDTA (1) 0.05 Guar hydroxypropyltrimonium chloride (2) 0.05 Polyquaternium-10 (3) 0.075 B NaOH (10% water solution) 0.30 C Lauryl ammonium sulfate (4) 34.00 Laureth ammonium sulfate ® 9.25 Cocamidopropyl betaine (6) 2.00 Dimeticona (y) pareth-4 of C1213 (y) pareth-23 of C1213 (y) salicylic acid (7) 2.50 D Cetylic alcohol 1.20 Cocamida MEA (9) 1.50 Glycol diestearate 2.00 E Methylcloroisothiazolinona y methylisotiazolinona (11) 0.10 D-Pantenol al 75% (12) 0.10 Desiccated water 0.30 F Sodium chloride (solution 25% watery) 0.60 CACznn / zznz / E / YiAi(1> EDETA® B Powder; origin: BASF(2)Jaguar® C14 S; origin: Rhodia(3> JR-400 Polymer from Ucare®; origin: Noveon(4)Sulfetal® LA BE; origin: Zschimmer & Schwarz(5)Zetesol® LA; origin: Zschimmer & Schwarz(6)Betaine F 50 from Tego®; origin: Evonik <7) Xiameter® MEM-1691; origin: Dow Corning(8)Lanette® 16; origin: BASF(9)Comperlan® 100; origin: Cognis(10)Cutina® AGS; origin: Cognis(11> Kathon® CG; origin: Rohm & Haas(12)D-panthenol; origin: Roche A perfumed pearlescent shampoo formulation was obtained by adding, under gentle stirring, a perfume oil (0.1 to 0.8% by weight relative to the total weight of the unperfumed shampoo formulation) and at least one of the compounds in formula (I) (0.05 to 0.5% by weight relative to the total weight of the unperfumed shampoo formulation) to the unperfumed pearlescent shampoo formulation listed in Table 6. Example 9 Preparation of rinse-out hair conditioner formulations comprising a compound of formula (I) of the invention Table 7 lists a typical unscented rinse-out hair conditioner formulation. The unscented rinse-out hair conditioner formulation was prepared by mixing the Phase A ingredients until a uniform mixture was obtained. Tylose® was allowed to dissolve completely. The mixture was then heated to 70–75°C. The Phase B ingredients were combined and melted at 70–75°C. The Phase B ingredients were then added to Phase A with good stirring, and mixing continued until the mixture reached a temperature of 60°C. The Phase C ingredients were then added under stirring, and mixing continued until the mixture cooled to 40°C. The pH was adjusted to 3.5 with a citric acid solution. 4.0. Table 7: Composition of a typical rinse-out hair conditioner formulation CRCznn / zznz / E / YiAi Phase Ingredients Quantity [% by weight] A Deionized water 81.8 Behentrimonium chloride ω 2.5 Hydroxyethylcellulose (2) 1.5 B Cetearyl alcohol (3) 4.0 Glyceryl stearate (and) PEG-100 stearate (4) 2.0 Behentrimonium methosulfate (and) cetyl alcohol (and) butylene glycol (5) 4.0 Ethoxy (20) stearyl alcohol (6) 1.0 C Amodimethicone (and) Trideceth-12 (and) cetrimonium chloride (7) 3.0 Chlorhexidine digluconate (20% aqueous solution) (8) 0.2 D Citric acid (10% aqueous solution at pH 3.5-4.0) qs (1)Genamin® KDMP; origin: Clariant(2)Tylose® H10 Y G4; origin: Shin Etsu ^3^ Lanette® O; origin: BASF(4> Arlacel® 165; origin: Croda(5)Behenyl TMS-50-PA-(MH) by Incroquat®; origin: Croda te) S20; origin: Croda(7)Xiameter® MEM-949; origin: Dow Corning(8)Origin: Alfa Aesar A perfumed rinse-out hair conditioner formulation was obtained by adding, under gentle stirring, a perfume oil (0.2 to 1.0% by weight relative to the total weight of the unscented conditioner formulation) and at least one of the compounds in formula (I) (0.05 to 0.5% by weight relative to the total weight of the unscented conditioner formulation) to the unscented rinse-out hair conditioner formulation listed in Table 7. Example 10 Preparation of structured shower gel formulations comprising a compound of formula (I) of the invention Table 8 lists a typical unscented structured shower gel formulation. A scented structured shower gel was prepared by adding, under gentle stirring, a perfume oil (0.1 to 1.5% by weight relative to the total weight of the structured shower gel) and at least one of the compounds of formula (I) of the invention (0.05 to 0.5% by weight relative to the total weight of the structured shower gel) to the unscented structured shower gel formulation of Table 8. Table 8: Composition of a typical unscented structured shower gel formulation CRCznn / zznz / E / viAi Ingredients Quantity [% by weight] Deionized water 49.35 Tetrasodium EDTA (1) 0.05 Acrylates copolymer (2; 6.00 Sodium C12-15 pareth sulfate (3) 35.00 Sodium hydroxide (20% aqueous solution) 1.00 Cocamidopropyl betaine (4) 8.00 Methylchloroisothiazolinone and methylisothiazolinone (5) 0.10 Citric acid (40% aqueous solution) 0.50 (1)EDETA B powder; origin: BASF(2)Carbopol Water Polymer SF-1; origin: Noveon(3)Zetesol AO 328 U; origin: Zschimmer & Schwarz(4)Betaina F 50 from Tego; origin: Goldschmidt(5> Kathon® CG; origin: Rohm & Haas Example 11 Preparation of transparent shower gel formulations comprising a compound of formula (I) of the invention Table 9 lists a typical unscented clear shower gel formulation. A scented clear shower gel was prepared by adding, under gentle stirring, a perfume oil (0.5 to 1.5% by weight relative to the total weight of the clear shower gel) and at least one of the compounds of formula (I) of the invention (0.05 to 0.5% by weight relative to the total weight of the clear shower gel) to the unscented clear shower gel formulation of Table 9. Table 9: Composition of a typical unscented clear shower gel formulation CRCznn / zznz / E / YiAi Ingredients Quantity [% by weight] Deionized water 52.40 Tetrasodium EDTA (1) 0.10 Sodium benzoate 0.50 Propyl glycol 2.00 Sodium C1215 polypeptide sulfate (2) 35.00 Cocamidopropyl betaine (3) 8.00 Polyquaternium-7 (4) 0.20 Citric acid (40% aqueous solution) 1.00 Sodium chloride 0.80 CACznn / zznz / E / YiAi(1> EDETA B powder; origin: BASF(2)Zetesol AO 328 U; origin: Zschiimer & Schwarz(3> Betaina F 50 from Tego; origin: Goldschmidt(4> Merquat® 550; origin: Lubrizol Example 12 Preparation of milky shower gel formulations comprising a compound of formula (I) of the invention Table 10 lists a typical unscented milky shower gel formulation. A scented milky shower gel was prepared by adding, under gentle stirring, a perfume oil (0.1 to 1.5% by weight relative to the total weight of the milky shower gel) and at least one of the compounds of formula (I) of the invention (0.05 to 0.5% by weight relative to the total weight of the milky shower gel) to the unscented milky shower gel formulation of Table 10. Table 10: Composition of a typical unscented milky shower gel formulation Ingredients Quantity [% by weight] Deionized water 50.95 Tetrasodium EDTA (1) 0.05 Sodium benzoate 0.50 Glycerin (86% aqueous solution) 3.50 Sodium laureth sulfate (2) 27.00 100 Polyquaternium-7 (3) 1.00 Coco-betaine (4) 6.00 PEG-120 methyl glucose trioleate (5) 1.00 Citric acid (40% aqueous solution) 1.00 Glycol distearate and laureth-4 and cocamidopropyl betaine (6) 3.00 Sodium chloride (20% aqueous solution) 5.00 PEG-40 hydrogenated castor oil (7) 1.00 CRCznn / zznz / E / Yi(1)EDETA® B powder; origin: BASF(2)Texapon® NSO IS; origin: Cognis(3)Merquat® 550; origin: Lubrizol(4)Dehyton® AB-30; origin: Cognis(5)Glucamate® LT; origin: Lubrizol Euperlan® PK 3000 AM; origin: Cognis(7> Cremophor® RH 40; origin: BASF Example 13 Preparation of anhydrous antiperspirant aerosol formulations comprising a compound of formula (I) of the invention Table 11 lists a typical fragrance-free, anhydrous antiperspirant spray formulation. The anhydrous antiperspirant spray formulation was prepared using a high-speed mixer. Silica and quaternium-18-hectorite were added to the isopropyl myristate and cyclomethicone mixture. Once fully expanded, aluminum chlorohydrate was added in portions under stirring until the mixture became homogeneous and lump-free. 101 Table 11: Composition of a typical unscented anhydrous antiperspirant spray CRCznn / zznz / E / viAi Ingredients Quantity [% by weight] Cyclomethicone (1) 53.51 Isopropyl myristate 9.04 Silica (2) 1.03 Quaternium-18-hectorite (3) 3.36 Aluminum chlorohydrate (4) 33.06 (1) Dow Corning® 345 Fluid; source: Dow Corning <2) Aerosil® 200; source: Evonik (3) Bentone® 38; source: Elementis Specialities <4> Micro Dry Ultrafine; origin: Reheis The perfumed formulation was then obtained by adding a perfume oil (0.85% by weight with respect to the total weight of the antiperspirant aerosol formulation) and at least one of the compounds of formula (I) of the invention (0.15% by weight with respect to the total weight of the antiperspirant aerosol formulation) to the unscented antiperspirant aerosol formulation of Table 11. Example 14 Preparation of deodorant aerosol emulsion formulations comprising a compound of formula (I) of the invention A typical deodorant aerosol emulsion formulation was prepared by mixing and dissolving all the 102 ingredients according to the sequence in Table 12. Then, a perfume oil (1.35% by weight with respect to the total weight of the deodorant aerosol formulation) and at least one of the compounds of formula (I) of the invention 5 (0.10-0.20% by weight with respect to the total weight of the deodorant aerosol formulation) were added under gentle stirring. The aerosol cans were then filled, crimped, and the propellant added. Aerosol filling: 40% active solution, 60% propane / butane (2.5 bar). Table 12: Composition of a deodorant aerosol formulation CRCznn / zznz / E / Yi typical unscented Ingredients Quantity [% by weight] Ethanol (95%) 90.65 Triclosan (l) 0.26 Isopropyl myristate 9.09 (1)Irgasan® DP 300; origin: BASF Example 15 Preparation of deodorant stick formulations comprising a compound of formula (I) of the invention A typical deodorant stick formulation was obtained by weighing all the components of Part A (Table 13) and heating them to 70–75 °C. Ceteareth-25 was added once the other ingredients of Part A were mixed and heated. When the Ceteareth-25 dissolved, stearic acid was added. Part B was prepared by dissolving triclosan in 1,225 propylene glycol (Table 13). Evaporated water was compensated for. 103 Then, slowly, under low mixing, part B was poured into part A. Table 13: Composition of a typical unscented deodorant stick formulation CRCznn / zznz / E / Yi Phase Ingredients Quantity [% by weight] A Stearic acid 5.05 1,2-Propylene glycol 41.87 Sodium hydroxide (20% aqueous solution) 4.24 Water 30.30 Tetrasodium EDTA (1) 0.10 Ceteareth-25 (2) 1.52 PPG-3 myristyl ether (3) 1.52 B 1,2-Propylene glycol 15.14 Triclosan (4) 0.25 (1)Edeta® B powder; origin: BASF(2)Cremophor® A2 5; origin: BASF(3)Tegosoft® APM; origin: Evonik(4> Irgasan® DP 300; origin: BASF A perfume oil (0.85% by weight of the total weight of the deodorant stick formulation) and at least one of the compounds from formula (I) of the invention (0.10-0.20% by weight of the total weight of the deodorant stick formulation) were added under gentle stirring. For storage, a plastic bag was placed in the bucket and sealed after cooling. The molds were filled to approximately 70 C. 104 Example 16 Preparation of deodorant formulations in a rotating ball device comprising a compound of formula (I) of the invention Table 14 lists a typical unscented rotary ball deodorant formulation. Part A was prepared by slowly spraying hydroxyethylcellulose into water while rapidly agitating with a turbine until the hydroxyethylcellulose fully expanded, forming a clear gel. Part B was then slowly poured into Part A while continuously agitating until the mixture was homogenized. Part C was then added. CRCznn / zznz / E / Yi Table 14: Composition of a deodorant formulation in a typical unscented rotary ball device Phase Ingredients Quantity [% by weight] A Water 50.51 Hydroxyethylcellulose (1) 0.71 B Ethanol (95%) 40.40 1,2-Propylene glycol 5.05 Triclosan (2) 0.30 C PEG-40 hydrogenated castor oil (3) 3.03 (1)Natrosol® 250 H; origin: Ashland ^23Irgasan® DP 300; origin: BASF ^3^ Cremophor® RH 40; origin: BASF The formulation of deodorant in a device The 105 perfumed rotating ball was obtained by adding a perfume oil (0.85% by weight with respect to the total weight of the deodorant stick formulation) and at least one of the compounds of formula (I) of the invention (0.10-0.20% by weight with respect to the total weight of the deodorant stick formulation) under gentle stirring. Example 17 Preparation of O / W emulsions based on day cream comprising a compound of formula (I) of the invention Table 15 lists a typical O / W emulsion formulation for a day cream comprising a compound of formula (I) of the invention. Phases A and B were heated separately to 70-75°C, then phase A was added to phase B and a vacuum was applied. The mixture was stirred and cooled to 55°C for 15 minutes. After cooling to room temperature, phenoxyethanol and piroctone olamine (part C) were added when a temperature of 45°C was reached. The mixture was stirred for 5 minutes before adding sodium carbomer (part D), a perfume oil, and at least one of the compounds of formula (I) of the invention (part E). The mixture was stirred for 3 minutes, then stirring was stopped for 15 minutes. When the mixture reached 30°C, stirring was resumed for another 15 minutes until the cream became smooth, glossy, and lump-free. If necessary, the pH was adjusted to 6.70-7.20 with Glydant®, Phenoni®po Nipaguard®. CRCznn / zznz / E / Yi 106 RO5 or up to 6.30-7.00 with Nikkoguard®. Table 15: Composition of a typical O / W emulsion based on day cream Phase Ingredients Quantity [% by weight] A Steareth-2 (and) PEG-8 distearate (1) 5.0 Cityl alcohol 0.5 Ceteth-20 (and) glyceryl stearate (and) PEG-6 stearate (and) Steareth-20 (2) 4.0 Squalane (3) 1.0 Paraffin oil (4) 2.0 Petrolatum (5) 5.5 B Deionized water 75.9 Propylene glycol 5.0 C Phenoxyethanol (and) piroctone olamine (6) 0.6 D Sodium carbonate (7) 0.2 E Perfume oil 0.15 Compound of formula (I) 0.15 (1)Arlacel® 985; origin: Croda(2)Tetóse® 2561; origin: Gattefossé(3> Biolip P 90; origin: Gattefossé(4> Mineral oil 30-40 CPS(5)Petroleum jelly Nipaguard® PO 5; Origin: Clariant <7> PNC 400 Example 18 Preparation of dishwasher formulations for hand washing comprising a compound of formula (I) of the invention Table 16 lists a formulation of 107 Typical unscented handwashing dishwashing liquid. The unscented handwashing dishwashing liquid was prepared by mixing water with sodium hydroxide and diethanolamide. Linear alkylbenzene sulfonic acid was then added. After neutralization, the remaining ingredients were added and the pH was adjusted to 7-8 if necessary. CRCznn / zznz / E / Yi Table 16: Composition of a typical unscented handwashing dishwashing formulation Ingredients Quantity [% by weight] Linear alkylbenzene sulfonic acid(1) 20.0 Diethanolamide (2) 3.5 Sodium hydroxide (50%)(3) 3.4 Secondary alcohol ethoxolate (4) 2.5 Sodium xylene sulfonate 6.3 Water 64.3 (1)Biosoft® S-118; origin: Stepan Ninol® 40-CO; origin: Stepan(3)Stepanate® SXS; origin: Stepan(4> Tergitol® 15-S-9; origin: Dow Chemicals The perfumed handwashing dishwashing formulation was obtained by adding a perfume oil (0.85% by weight with respect to the total weight of the handwashing dishwashing formulation) and at least one of the compounds of formula (I) of the invention (0.10-0.20% by weight with respect to the total weight of the dishwashing formulation) under gentle stirring. 108 It is hereby stated that, as of this date, the best method known to the applicant for putting the aforementioned invention into practice is the one that is clear from the present description of the invention.
Claims
1. A compound of the formula, R1 R1' CRCznn / zznz / E / Yi characterized in that R1 and R1' independently represent each other a hydrogen atom or a methyl group; or, both R1 and / or both R1', when taken together, represent a divalent hydrocarbon group from Ca to Cs, R2 and R2' independently represent each other a hydrogen atom or a hydrocarbon group from Ci to C12, R3 and R3' independently represent each other a hydrogen atom or a hydrocarbon group from Ci to Cie; or R1 and R3 and / or R1' and R3', when taken together, represent a C2 to C12 divalent hydrocarbon group, Q represents a C2 to C22 divalent hydrocarbon group, optionally comprising one to eight ether groups and / or one or two functional groups selected from the group consisting of alcohol, benzoin, aldehyde, ester, thioether, carboxylic acid, alkali carboxylate, amine, amide, carbamate, nitrile or thiol;and each X independently represents any of the groups of formulas (i) to (iii) CRCznn / zznz / B / Yi where the wavy line indicates the location of the bond between carbons 2 or 2' and X and the dashed line indicates the location of the bond between X and Q, provided that the dashed line is not directly attached to a heteroatom or a carbonyl functional group of Q.; 2. The compound according to claim 1, characterized in that R1 and R1' represent a hydrogen atom or a methyl group, R2 and R2' represent a methyl or ethyl group, and R3 and R3' represent a hydrogen atom or a hydrocarbon group from C1 to C10; or R1 and R3 and / or R1' and R3', when taken together, represent a divalent hydrocarbon group from C2 to C10, X represents the groups of formula (i) and / or (ii), and Q represents a divalent alkyl or alkenyl group from C2 to C10, preferably from C4 to C11, optionally comprising one to four ether groups and / or one or two functional groups selected from the group consisting of ester, alcohol, amine, or carbamate.
3. The compound according to any of claims 1 and 2, characterized in that Q represents butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, 3-oxapentyl, 3,6-dioxaoctyl, 3,6,9-trioxaundecyl, 3,6,9,12-tetraoxatetradecyl.
4. The compound according to any one of claims 1 to 3, characterized in that the compound of formula (I) is a compound of formula R1 CRCznn / zznz / E / YiAi wherein R1, R2, R3, X and Q have the same meaning according to any one of claims 1 to 3.
5. The compound according to any one of claims 1 to 4, characterized in that the compound of formula (I) is a compound of formula OO wherein X and Q have the same meaning according to any one of claims 1 to 3. 112 6. The compound according to any of claims 1 to 3 CRCznn / zznz / B / Yi characterized in that the compound of formula (I) is a compound of the formula wherein R1, R2, R3, X and Q have the same meaning according to any of claims 1 to 3, and wherein the dashed lines represent the location of a single or double bond.
7. The compound according to any of claims 1 to 3 and 6, characterized in that the compound of formula (I) is a compound of the formula wherein R1, X and Q have the same meaning according to any of claims 1 to 3, and wherein the dotted lines represent the location of a single or double bond.
8. The compound according to any one of claims 1 to 3, characterized in that the compound of formula (I) is a compound of formula 25 113 R1 CRCznn / zznz / B / Yi wherein R1, R2, R3 and Q have the same meaning according to any one of claims 1 to 3.
9. The compound according to any one of claims 1 to 3 and 8, characterized in that the compound of formula (I) is a compound of formula (If) wherein Q has the same meaning according to any one of claims 1 to 3.
10. The use of a compound of formula (I) according to claims 1 to 9 as a perfume ingredient to provide a long-lasting fresh green, floral and / or fruity scent to the environment.
11. A method for conferring, enhancing, improving or modifying the fresh green, floral and / or fruity scent properties of a perfume composition or perfumed article, characterized in that it comprises adding to the composition or article an effective amount of at least one compound of formula (I) in accordance with any of claims 1 to 9.
12. A perfume composition, characterized in that 114 comprises: i) as a perfume ingredient, at least one compound of formula (I) according to any one of claims 1 to 9; ii) at least one ingredient selected from the group consisting of a perfume carrier and a perfume base; and iii) optionally at least one perfume adjuvant.
13. A perfumed consumer product, characterized in that it comprises, as a perfume ingredient, at least one compound of formula (I) according to any one of claims 1 to 9, or a perfume composition according to claim 12.
14. The perfumed consumer product according to claim 13, characterized in that the perfumery consumer product is a perfume, a fabric care product, a body care product, an air care product or a home care product, preferably wherein the perfumery consumer product is a fine perfume, a liquid or solid detergent, a fabric softener, a fabric refresher, ironing water, a shampoo, a dyeing preparation, a hairspray, a deodorant or antiperspirant, a perfumed soap, a shower or bath foam, an oil or gel, a hygiene product, an air freshener, a ready-to-use powder air freshener or a hard surface detergent.
15. A method for imparting a long-lasting or substantive fresh, floral and / or fruity green scent to surfaces, such as hard surfaces, fabrics, skin or hair, characterized in that at least one compound of formula (I) according to claims 1 to 9 is added to the perfume compositions or perfumed articles and applied to the corresponding target surface.